Global Medical REIT (GMRE) 10-Q 6 Nov 18 2018 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2018	Nov. 02, 2018
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2018
Document Fiscal Year Focus	2,018
Document Fiscal Period Focus	Q3
Entity Registrant Name	Global Medical REIT Inc.
Entity Central Index Key	1,533,615
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Trading Symbol	GMRE
Entity Common Stock, Shares Outstanding		22,027,122
Entity Emerging Growth Company	false
Entity Small Business	false

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Investment in real estate:
Land	$ 56,839	$ 42,701
Building	493,503	384,338
Site improvements	6,714	4,808
Tenant improvements	14,328	8,010
Acquired lease intangible assets	41,653	31,650
Real Estate Investment Property, at Cost, Total	613,037	471,507
Less: accumulated depreciation and amortization	(26,839)	(13,594)
Investment in real estate, net	586,198	457,913
Cash and cash equivalents	3,005	5,109
Restricted cash	817	2,005
Tenant receivables	1,744	704
Escrow deposits	2,628	1,638
Deferred assets	8,590	3,993
Other assets	1,109	459
Total assets	604,091	471,821
Liabilities:
Revolving credit facility, net of unamortized discount of $4,127 and $2,750 at September 30, 2018 and December 31, 2017, respectively	293,273	162,150
Notes payable, net of unamortized discount of $832 and $930 at September 30, 2018 and December 31, 2017, respectively	38,643	38,545
Accounts payable and accrued expenses	4,420	2,020
Dividends payable	6,109	5,638
Security deposits and other	3,928	2,128
Due to related parties, net	1,028	1,036
Acquired lease intangible liability, net	2,034	1,291
Total liabilities	349,435	212,808
Stockholders' equity:
Preferred stock, $0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at September 30, 2018 and December 31, 2017 (liquidation preference of $77,625 at September 30, 2018 and December 31, 2017)	74,959	74,959
Common stock, $0.001 par value, 500,000 shares authorized; 22,003 shares and 21,631 shares issued and outstanding at September 30, 2018 and December 31, 2017	22	22
Additional paid-in capital	208,938	205,788
Accumulated deficit	(46,855)	(34,434)
Accumulated other comprehensive loss	(109)	0
Total Global Medical REIT Inc. stockholders' equity	236,955	246,335
Noncontrolling interest	17,701	12,678
Total stockholders' equity	254,656	259,013
Total liabilities and stockholders' equity	$ 604,091	$ 471,821

Consolidated Balance Sheets _Pa

Consolidated Balance Sheets [Parenthetical] - USD ($) shares in Thousands, $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Debt Instrument, Unamortized Discount	$ 832	$ 930
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000	10,000
Preferred stock, shares issued	3,105	3,105
Preferred stock, shares outstanding	3,105	3,105
Preferred Stock, Liquidation Preference, Value	$ 77,625	$ 77,625
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	500,000	500,000
Common stock, shares issued	22,003	21,631
Common stock, shares outstanding	22,003	21,631
Revolving credit facility [Member]
Debt Instrument, Unamortized Discount	$ 4,127	$ 2,750
Notes Payable [Member]
Debt Instrument, Unamortized Discount	$ 832	$ 930

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018		Sep. 30, 2017
Revenue
Rental revenue	$ 13,111	$ 7,922	$ 36,180		$ 19,218
Expense recoveries	884	444	2,610		1,141
Other income	8	23	27		112
Total revenue	14,003	8,389	38,817		20,471
Expenses
General and administrative	1,395	990	4,169		4,418
Operating expenses	941	464	2,726		1,235
Management fees - related party	1,104	804	3,280	[1]	2,059
Depreciation expense	3,614	2,176	9,965		5,372
Amortization expense	953	523	2,645		1,326
Interest expense	4,055	2,174	10,681		5,266
Acquisition fees	168	652	294		2,130
Total expenses	12,230	7,783	33,760		21,806
Net income (loss)	1,773	606	5,057		(1,335)
Less: Preferred stock dividends	(1,455)	(259)	(4,366)		(259)
Less: Net (income) loss attributable to noncontrolling interest	(32)	34	(59)		34
Net income (loss) attributable to common stockholders	$ 286	$ 381	$ 632		$ (1,560)
Net income (loss) attributable to common stockholders per share – basic and diluted	$ 0.01	$ 0.02	$ 0.03		$ (0.08)
Weighted average shares outstanding – basic and diluted	21,797	21,522	21,687		18,938
[1]	Net amount accrued of $41 consists of $3,280 in management fee expense incurred, net of $3,239 of accrued management fees that were paid to the Advisor. This represents a cash flow operating activity.

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Net income (loss)	$ 1,773	$ 606	$ 5,057	$ (1,335)
Other comprehensive income (loss):
Decrease in fair value of interest rate swap agreement	(109)	0	(109)	0
Total other comprehensive loss	(109)	0	(109)	0
Comprehensive income (loss)	1,664	606	4,948	(1,335)
Less: Preferred stock dividends	(1,455)	(259)	(4,366)	(259)
Less: Comprehensive (income) loss attributable to noncontrolling interest	(21)	34	(48)	34
Comprehensive income (loss) attributable to common stockholders	$ 188	$ 381	$ 534	$ (1,560)

Consolidated Statement of Stock

Consolidated Statement of Stockholders' Equity - 9 months ended Sep. 30, 2018 - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock [Member]	Preferred Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Loss [Member]	GMR Equity [Member]	Noncontrolling Interest [Member]
Balances, December 31, 2017 at Dec. 31, 2017	$ 259,013	$ 22	$ 74,959	$ 205,788	$ (34,434)	$ 0	$ 246,335	$ 12,678
Balance (Shares) at Dec. 31, 2017		21,631	3,105
Net income	5,057	$ 0	$ 0	0	4,998	0	4,998	59
Issuance of shares of common stock	3,452	$ 0	$ 0	3,452	0	0	3,452	0
Issuance of shares of common stock (Shares)		372	0
Reclassification of deferred offering costs	(302)	$ 0	$ 0	(302)	0	0	(302)	0
Change in fair value of interest rate swap	(109)	0	0	0	0	(109)	(109)	0
Stock-based compensation expense	1,978	0	0	0	0	0	0	1,978
Dividends to common stockholders	(13,053)	0	0	0	(13,053)	0	(13,053)	0
Dividends to preferred stockholders	(4,366)	0	0	0	(4,366)	0	(4,366)	0
Dividends to noncontrolling interest	(1,493)	0	0	0	0	0	0	(1,493)
OP Units issued to third parties	4,742	0	0	0	0	0	0	4,742
LTIP Units redeemed in cash	(263)	0	0	0	0	0	0	(263)
Balances, September 30, 2018 at Sep. 30, 2018	$ 254,656	$ 22	$ 74,959	$ 208,938	$ (46,855)	$ (109)	$ 236,955	$ 17,701
Balances (Shares) at Sep. 30, 2018		22,003	3,105

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Operating activities
Net income (loss)	$ 5,057	$ (1,335)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation expense	9,965	5,372
Amortization of acquired lease intangible assets	2,645	1,326
Amortization of above market leases, net	484	14
Amortization of deferred financing costs and other	1,327	840
Stock-based compensation expense	1,978	1,481
Advisory expense settled in OP Units	0	77
Capitalized pre-acquisition costs charged to expense	132	0
Changes in operating assets and liabilities:
Tenant receivables	(1,040)	(404)
Deferred assets	(4,597)	(2,219)
Other assets	(126)	(22)
Accounts payable and accrued expenses	1,434	1,622
Security deposits and other	1,800	1,487
Accrued management fees due to related party	41	183
Net cash provided by operating activities	19,100	8,422
Investing activities
Purchase of land, buildings, and other tangible and intangible assets and liabilities	(133,851)	(213,535)
Escrow deposits for purchase of properties	(774)	(60)
(Loans to) repayments from related parties	(49)	38
Payments for tenant improvements	(2,014)	0
Pre-acquisition costs for purchase of properties	257	51
Net cash used in investing activities	(136,431)	(213,506)
Financing activities
Net proceeds received from preferred stock offering	0	75,147
Net proceeds received from common equity offerings	3,209	33,795
Escrow deposits required by third party lenders	(216)	(24)
Borrowings from related parties	0	0
Repayment of note payable from related party	0	(421)
Proceeds from revolving credit facility	142,900	205,400
Repayment of revolving credit facility	(10,400)	(107,000)
Payments of deferred financing costs	(2,750)	(2,793)
Redemption of LTIP Units	(263)	0
Dividends paid to common stockholders, and OP Unit and LTIP Unit holders	(14,075)	(10,815)
Dividends paid to preferred stockholders	(4,366)	0
Net cash provided by financing activities	114,039	193,289
Net decrease in cash and cash equivalents and restricted cash	(3,292)	(11,795)
Cash and cash equivalents and restricted cash—beginning of period	7,114	20,612
Cash and cash equivalents and restricted cash—end of period	3,822	8,817
Supplemental cash flow information:
Cash payments for interest	9,106	3,928
Noncash financing and investing activities:
Accrued dividends payable	5,995	4,767
Reclassification of common stock offering costs to additional paid-in capital	302	443
Accrued pre-acquisition costs for purchase of properties and tenant improvements	774	0
OP Units issued for noncash transaction	4,742	1,000
Accrued preferred stock offering costs	0	188
Reclassification of preferred stock offering costs to preferred stock balance	0	221
Construction in Progress [Member]
Noncash financing and investing activities:
Construction-in-process completed and transferred to real estate investments	2,043	0
Interest Rate Swap [Member]
Noncash financing and investing activities:
Interest rate swap fair value change recognized in other comprehensive loss	$ 109	$ 0

Organization

Organization	9 Months Ended
	Sep. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	Note 1 – Organization Global Medical REIT Inc. (the “Company”) is a Maryland corporation engaged primarily in the acquisition of licensed, state-of-the-art, purpose-built healthcare facilities and the leasing of these facilities to strong clinical operators with leading market share. The Company is externally managed and advised by Inter-American Management, LLC (the “Advisor”). The Company holds its facilities and conducts its operations through a Delaware limited partnership subsidiary named Global Medical REIT L.P. (the “Operating Partnership”) and the Operating Partnership’s wholly-owned subsidiaries. The Company, through a wholly-owned subsidiary, serves as the sole general partner of the Operating Partnership. As of September 30, 2018, the Company was the 90.0% limited partner of the Operating Partnership, with an aggregate of 10.0% owned by holders of long-term incentive plan (“LTIP”) units and third-party holders of Operating Partnership units (“OP Units”).

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2018
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	Note 2 – Summary of Significant Accounting Policies Basis of presentation The accompanying financial statements are unaudited and include the accounts of the Company, including the Operating Partnership and its wholly-owned subsidiaries. The accompanying financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and the rules and regulations of the United States Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures required for annual financial statements have been condensed or excluded pursuant to SEC rules and regulations. Accordingly, the accompanying financial statements do not include all of the information and footnotes required by GAAP for complete financial statements and should be read in conjunction with the audited financial statements and notes thereto for the fiscal year ended December 31, 2017. In the opinion of management, all adjustments of a normal and recurring nature necessary for a fair presentation of the financial statements for the interim periods have been made. Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company, including the Operating Partnership and its wholly-owned subsidiaries. The Company presents the portion of any equity it does not own but controls (and thus consolidates) as noncontrolling interest. Noncontrolling interest in the Company includes the LTIP units that have been granted to the Company’s and Advisor’s directors, officers and employees and the OP Units held by third parties. Refer to Note 5 – “Stockholders’ Equity” and Note 7 – “Stock-Based Compensation” for additional information regarding the LTIP units and OP Units. The Company classifies noncontrolling interest as a component of consolidated equity on its Consolidated Balance Sheets, separate from the Company’s total stockholders’ equity. The Company’s net income or loss is allocated to noncontrolling interests based on the respective ownership or voting percentage in the Operating Partnership associated with such noncontrolling interests and is removed from consolidated income or loss on the Consolidated Statements of Operations in order to derive net income or loss attributable to common stockholders. The noncontrolling ownership percentage is calculated by dividing the aggregate number of LTIP units and OP Units held by the total number of shares of common stock and units outstanding. Any future issuances of additional LTIP units or OP Units would change the noncontrolling ownership interest. Use of Estimates The preparation of the consolidated financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and footnotes. Actual results could differ from those estimates. Cash and Cash Equivalents and Restricted Cash On January 1, 2018 the Company adopted the provisions of Accounting Standards Update (“ASU”) 2016-18, “Statement of Cash Flows (Topic 230) Restricted Cash” (“ASU 2016-18”) , which requires that the statement of cash flows explain the change during the period in the total of cash and cash equivalents and amounts generally described as restricted cash. In accordance with the requirements of ASU 2016-18, the following table provides a reconciliation of the Company’s cash and cash equivalents and restricted cash that sums to the total of those amounts at the end of the periods presented on the Company’s accompanying Consolidated Statements of Cash Flows for the nine months ended September 30, 2018 and 2017: As of September 30, 2018 2017 Cash and cash equivalents $ 3,005 $ 6,777 Restricted cash 817 2,040 Total cash and cash equivalents and restricted cash (1) $ 3,822 $ 8,817 (1) Represents the total of the amounts at the end of the periods presented on the Consolidated Statements of Cash Flows as required by ASU 2016-18. The cash and cash equivalents and restricted cash balance as of December 31, 2017 and December 31, 2016 (the beginning balances of the periods presented) was $7,114 and $20,612, respectively. The Company considers all demand deposits, cashier’s checks, money market accounts, and certificates of deposit with a maturity of three months or less to be cash equivalents. Amounts included in restricted cash represent (1) certain security deposits received from tenants at the inception of their leases; (2) cash required to be held by a third-party lender as a reserve for debt service; and (3) funds held by the Company that were received from certain tenants that the Company collected to pay specific tenant expenses, such as real estate taxes and insurance, on the tenant’s behalf. Tenant Receivables The tenant receivable balance as of September 30, 2018 and December 31, 2017 was $1,744 and $704, respectively. The balance as of September 30, 2018 consisted of $621 in funds owed from the Company’s tenants for rent that the Company had earned but had not yet received and $1,062 in funds owed by certain of the Company’s tenants for amounts the Company collects to pay specific tenant expenses, such as real estate taxes and insurance, on the tenants’ behalf. Additionally, as of September 30, 2018 the balance included $61 in miscellaneous receivables. The balance as of December 31, 2017 consisted of $125 in funds owed from the Company’s tenants for rent that the Company had earned but had not yet received, and $579 in funds owed by certain of the Company’s tenants for amounts the Company collects to pay specific tenant expenses, such as real estate taxes and insurance, on the tenants’ behalf. Escrow Deposits The escrow balance as of September 30, 2018 and December 31, 2017 was $2,628 and $1,638, respectively. Escrow deposits include funds held in escrow to be used for the acquisition of properties in the future and for the payment of taxes, insurance, and other amounts as stipulated by the Company’s Cantor Loan, as hereinafter defined. Deferred Assets The deferred assets balance as of September 30, 2018 and December 31, 2017 was $8,590 and $3,993, respectively. The balance as of September 30, 2018 consisted of $7,813 in deferred rent receivables resulting from the recognition of revenue from leases with fixed annual rental escalations on a straight-line basis and the balance of $777 represented other deferred costs. The balance as of December 31, 2017 consisted of $3,842 in deferred rent receivables resulting from the recognition of revenue from leases with fixed annual rental escalations on a straight-line basis and the balance of $151 represented other deferred costs. Other Assets The other assets balance as of September 30, 2018 and December 31, 2017 was $1,109 and $459, respectively. The balance as of September 30, 2018 consisted primarily of $521 in construction-in-process related to tenant improvements (which was accrued and not paid as of September 30, 2018). Additionally, the balance included $180 in capitalized costs related to property acquisitions, $139 related to an interest rate swap asset (refer to the “Derivative Instrument – Interest Rate Swap” disclosure herein), and $269 in a prepaid asset. The balance as of December 31, 2017 consisted of $316 in capitalized costs related to property acquisitions and $143 in a prepaid asset. Security Deposits and Other The security deposits and other liability balance as of September 30, 2018 and December 31, 2017 was $3,928 and $2,128, respectively. The balance as of September 30, 2018 consisted of security deposits of $3,137 and a tenant impound liability of $791 related to amounts owed for specific tenant expenses, such as real estate taxes and insurance. The balance as of December 31, 2017 consisted of security deposits of $1,620 and a tenant impound liability of $508 related to amounts owed for specific tenant expenses. Derivative Instrument - Interest Rate Swap As disclosed in Note 4 – “Notes Payable and Revolving Credit Facility,” as of September 30, 2018, the Company had one interest rate swap derivative instrument that was designated as a cash flow hedge of interest rate risk. In accordance with the Company’s risk management strategy, the purpose of the interest rate swap is to manage interest rate risk for certain of the Company’s variable-rate debt. The interest rate swap involves the Company’s receipt of variable-rate amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreement. The Company accounts for derivative instruments in accordance with the provisions of Accounting Standards Codification (“ASC”) Topic 815, “Derivatives and Hedging.” Additionally, effective July 1, 2018, the Company adopted the provisions of Accounting Standards Update (“ASU”) No. 2017-12, “Derivatives and Hedging: Targeted Improvements to Accounting for Hedging Activities” (“ASU 2017-12”). The purpose of ASU 2017-12 is to better align a company’s financial reporting for hedging activities with the economic objectives of those activities. The adoption of ASU 2017-12 did not have a material impact on the Company’s consolidated financial statements or disclosures. Reclassification The Company reclassified the line item “Deferred Financing Costs, Net” on its Consolidated Balance Sheet as of December 31, 2017 to present this amount as a reduction of the Company’s “Revolving Credit Facility” liability balance. The deferred financing cost, net balance consists of costs incurred related to securing and amending the Company’s revolving credit facility (net of accumulated amortization). The reclassification was made to conform to the Company’s presentation of this line item in the Company’s Consolidated Balance Sheet as of September 30, 2018, which treats all unamortized deferred financing costs as a reduction of the debt balance. New Accounting Pronouncements Leases and Revenue Recognition In February 2016, the Financial Accounting Standards Board (FASB) issued ASU No. 2016-02 “Leases” (“ASU 2016-02”). This standard created Topic 842, Leases, and superseded FASB ASC Topic 840, “Leases.” ASU 2016-02 requires a lessee to recognize the assets and liabilities that arise from leases (both operating and finance leases). However, for leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election not to recognize lease assets and lease liabilities. The main difference between the existing guidance on accounting for leases and the new standard is that operating leases will now be recorded as assets and liabilities. The new standard requires lessors to account for leases using an approach that is substantially equivalent to existing guidance for operating leases. ASU 2016-02 is expected to impact the Company’s consolidated financial statements as the Company has certain operating ground lease arrangements for which it is the lessee and therefore will be required to recognize right of use assets and related lease liabilities on its consolidated balance sheets upon adoption of this new standard. Current GAAP requires only capital leases to be recognized on the balance sheet, and amounts related to operating leases largely are reflected in the financial statements as rent expense on the income statement and in notes to the financial statements. ASU 2016-02 is effective for annual reporting periods (including interim periods within those periods) beginning after December 15, 2018. Early adoption is permitted. Based on its anticipated election of the practical expedients, the Company anticipates that its leases where it is the lessor and several ground leases where the Company is the lessee will continue to be accounted for as operating leases under the new standard. Therefore, as of January 1, 2019, the Company does not currently anticipate significant changes in the accounting for its lease revenues and expenses. For the Company’s ground leases where it is the lessee, it will be required to recognize right of use assets and related lease liabilities on its consolidated balance sheets upon adoption. The Company will not be required to reassess the classification of existing leases where it is the lessor or existing ground leases where it is the lessee and therefore the leases would continue to be accounted for as operating leases. However, in the event the Company modifies existing leases or enters into new leases after adoption of the new standard, such leases may be classified as finance leases. The Company will continue to evaluate the impact of adopting the new leases standard on its consolidated statements of income and comprehensive income and consolidated balance sheets. In May 2014, with subsequent updates issued in August 2015 and March, April and May 2016, the FASB issued ASU 2014-09 “Revenue from Contracts with Customers (Topic 606)” (“ASU 2014-09”). ASU 2014-09 was developed to enable financial statement users to better understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The update’s core principle is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Companies are to use a five-step contract review model to ensure revenue is recognized, measured and disclosed in accordance with this principle. Those steps include the following: (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to each performance obligation in the contract, and (v) recognize revenue when or as the entity satisfies a performance obligation. The Company has identified four main revenue streams, three of which originate from lease contracts and will be subject to Leases ASU 2016-02, Topic 842 (described above) effective for annual reporting periods (including interim periods) beginning after December 15, 2018. The Company’s revenue streams are: Revenue Recognition (ASU 2014-09, Topic 610-20): (1) Gain (loss) on sale of real estate properties Leases (ASU 2016-02, Topic 842): (2) Rental revenues (3) Straight line rents (4) Tenant recoveries The Company adopted the provisions of ASU 2014-09 effective January 1, 2018 and concluded that all of the Company’s material revenue streams fall outside of the scope of this guidance. During the three and nine months ended September 30, 2018 and 2017, the Company sold no real estate properties and therefore had no revenue streams from that source. The new standard may be applied retrospectively to each prior period presented or prospectively with the cumulative effect, if any, recognized as of the date of adoption. The Company selected the modified retrospective transition method as of the date of adoption effective January 1, 2018. Management concluded that the majority of its total revenues consist of rental income from leasing arrangements, which is specifically excluded from the standard. The Company analyzed its remaining revenue streams and concluded there are no changes in revenue recognition with the adoption of the new standard. As such, adoption of ASU 2014-09 did not result in a cumulative adjustment recognized as of January 1, 2018, and the standard did not have a material impact on the Company’s consolidated financial statements or disclosures.

Property Portfolio

Property Portfolio	9 Months Ended
	Sep. 30, 2018
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	Note 3 – Property Portfolio Implementation of New Business Combination Accounting Standard Effective January 1, 2018, the Company adopted the provisions of ASU 2017-01 – “Business Combinations (Topic 805): Clarifying the Definition of a Business” (“ASU 2017-01”). ASU 2017-01 provides revised guidance to determine when an acquisition meets the definition of a business or alternatively should be accounted for as an asset acquisition. ASU 2017-01 requires that, when substantially all of the fair value of an acquisition is concentrated in a single identifiable asset or a group of similar identifiable assets, the asset or group of similar identifiable assets does not meet the definition of a business and therefore is required to be accounted for as an asset acquisition. Transaction costs will continue to be capitalized for asset acquisitions and expensed as incurred for business combinations. ASU 2017-01 will result in most, if not all, of the Company’s post-January 1, 2018 acquisitions being accounted for as asset acquisitions because substantially all of the fair value of the gross assets the Company acquires are concentrated in a single asset or group of similar identifiable assets. For asset acquisitions that are “owner occupied” (meaning that the seller either is the tenant or controls the tenant) the purchase price, including capitalized acquisition costs, will be allocated to land and building based on their relative fair values with no value allocated to intangible assets or liabilities. For asset acquisitions where there is a lease in place but not “owner occupied,” the Company will allocate the purchase price to tangible assets and any intangible assets acquired or liabilities assumed based on their relative fair values. Summary of Properties Acquired During the Nine Months Ended September 30, 2018 During the nine months ended September 30, 2018, the Company completed eight acquisitions. For all eight acquisitions, substantially all of the fair value of the acquisitions was concentrated in a single identifiable asset or group of similar identifiable assets and, therefore, all of the acquisitions represent asset acquisitions under the guidance provided by ASU 2017-01. Accordingly, transaction costs for these acquisitions were capitalized. A rollforward of the gross investment in land, building and improvements as of September 30, 2018, resulting from these acquisitions is as follows: Land Building Site & Tenant Improvements Acquired Lease Intangibles Gross Investment in Real Estate Balances as of January 1, 2018 $ 42,701 $ 384,338 $ 12,818 $ 31,650 $ 471,507 Facility Acquired – Date Acquired: Moline / Silvis – 1/24/18 - 4,895 1,216 989 7,100 Freemont – 2/9/18 162 8,335 - - 8,497 Gainesville – 2/23/18 625 9,885 - - 10,510 Dallas – 3/1/18 6,272 17,012 - - 23,284 Orlando – 3/22/18 2,543 11,720 756 1,395 16,414 Belpre – 4/19/18 3,025 50,526 3,966 7,166 64,683 McAllen – 7/3/18 1,099 4,296 5,395 Derby – 8/3/18 412 2,496 243 453 3,604 Tenant improvements (1) - - 2,043 - 2,043 Total Additions (2) 14,138 109,165 8,224 10,003 141,530 Balances as of September 30, 2018 $ 56,839 $ 493,503 $ 21,042 $ 41,653 $ 613,037 (1) Represents tenant improvements that were completed and placed in service during the three months ended September 30, 2018 related to the Silvis and Sherman facilities that were acquired in January 2018 and June 2017, respectively. These amounts were recorded as construction-in-process within the “Other Assets” line item in the Company’s Consolidated Balance Sheet as of June 30, 2018, and reclassified to investment in real estate once completed. (2) The Belpre acquisition included $4,742 of OP Units issued as part of the total consideration for the transaction. As indicated in (1) above, $2,043 of completed construction-in-process costs were reclassified to investment in real estate during the three months ended September 30, 2018. Additionally, an aggregate of $894 of intangible liabilities were acquired from the acquisitions that occurred during the nine months ended September 30, 2018. Accordingly, the total addition to gross investment in real estate funded with cash was $133,851. Depreciation expense was $3,614 and $9,965 for the three and nine months ended September 30, 2018, respectively, and $2,176 and $5,372 for the three and nine months ended September 30, 2017, respectively. As of September 30, 2018, the Company had aggregate capital improvement commitments to improve or expand existing tenant space of $17,003. Many of these commitments are subject to contingencies that make it difficult to predict when such commitments will be called upon, if at all. However, the Company expects to be obligated to spend approximately $721 in tenant improvements during 2018 (of which $521 was incurred as of September 30, 2018) in connection with its Sherman, Silvis, and Gainesville facilities. The following is a summary of the acquisitions completed during the nine months ended September 30, 2018. Moline / Silvis Facilities Moline Facility - On January 24, 2018, the Company purchased a medical office building located in Moline, Illinois, which included the seller’s interest, as ground lessee, in an existing ground lease. The ground lease has approximately 10 years remaining in the initial term, with 12 consecutive five-year renewal options. Upon the closing of this acquisition, the Company assumed two subleases: one sublease with Fresenius Medical Care Quad Cities, LLC (“Fresenius”) with approximately 13 years remaining in the initial term, with three consecutive five-year renewal options; and one sublease with Quad Cities Nephrology Associates, P.L.C. with approximately 15 years remaining in the initial term, with three consecutive five-year renewal options. Silvis Facility - On January 24, 2018, the Company purchased a medical office building located in Silvis, Illinois from the same seller as the Moline facility, which included the seller’s interest, as ground lessee, in an existing ground lease. The ground lease has approximately 67 years remaining in the initial term, with no renewal options. Upon the closing of this acquisition, the Company assumed one sublease with Fresenius with approximately 13 years remaining in the initial term, with three consecutive five-year renewal options. The aggregate purchase price for the Moline/Silvis facilities was $6.9 million. The following table presents the details of the tangible and intangible assets acquired and liabilities assumed for this acquisition: Site improvements $ 249 Building and tenant improvements 5,862 In-place leases 343 Above market ground lease intangibles 219 Leasing costs 427 Below market lease intangibles (229 ) Total purchase price $ 6,871 Fremont Facility - On February 9, 2018, the Company purchased a medical office building located in Fremont, Ohio for a purchase price of approximately $8.5 million. Upon the closing of this acquisition, the Company entered into a new 12-year lease with Northern Ohio Medical Specialists, LLC (NOMS) with four consecutive five-year renewal options. Gainesville Facility - On February 23, 2018, the Company purchased a medical office building and ambulatory surgery center located in Gainesville, Georgia for a purchase price of approximately $10.5 million. Upon the closing of this acquisition, the Company entered into a new 12-year lease with SCP Eye Care Services, LLC with four consecutive five-year renewal options. Dallas Facility - On March 1, 2018, the Company purchased a hospital, a three-story parking garage, and land all located in Dallas, Texas for an aggregate purchase price of $23.3 million. In addition to the hospital and the parking garage, the land underlays two medical office buildings that are not owned by the Company, each of which is ground leased to the hospital. Upon the closing of this acquisition, the Company entered into two leases with Pipeline East Dallas, LLC, with one lease relating to the hospital and the other lease relating to the underlying land and parking garage. Orlando Facilities - On March 22, 2018, the Company purchased five medical office buildings from five affiliated sellers for an aggregate purchase price of $16.4 million. Upon the closing of this acquisition, the Company assumed five existing leases with Orlando Health, Inc. One lease has approximately one year remaining in its initial term, with one 10-year renewal option; one lease has approximately six years remaining in its initial term, with three consecutive five-year renewal options; one lease has approximately six years remaining in its initial term, with four consecutive five-year renewal options; one lease has approximately six years remaining in its initial term, with three consecutive five-year renewal options; and one lease was amended at closing to extend the remaining term to five years with four consecutive five-year renewal options. The following table presents the details of the tangible and intangible assets acquired and liabilities assumed: Land and site improvements $ 3,075 Building and tenant improvements 11,944 In-place leases 808 Above market lease intangibles 229 Leasing costs 358 Below market lease intangibles (10 ) Total purchase price $ 16,404 Belpre Portfolio - On April 19, 2018, the Company purchased a portfolio of four medical office buildings and a right of first refusal to purchase a fifth, yet to be built, medical office building on the same campus, for an aggregate purchase price of $64.1 million. Upon the closing of the acquisition the Company assumed the existing leases with Marietta Memorial Hospital, a subsidiary of Memorial Health System and such leases had a weighted average remaining lease term of approximately 11.35 years, each with three consecutive five-year tenant renewal options. The following table presents the details of the tangible and intangible assets acquired and liabilities assumed: Land and site improvements $ 3,997 Building and tenant improvements 53,520 In-place leases 2,660 Above market lease intangibles 2,527 Leasing costs 1,979 Below market lease intangibles (632 ) Total purchase price $ 64,051 McAllen Facility - On July 3, 2018, the Company purchased a medical office building (and adjacent condominium) located in McAllen, Texas for a purchase price of $5.4 million. Upon the closing of this acquisition, the Company entered into a new 11-year lease with Valley Ear, Nose, and Throat Specialists, PA, with two consecutive 10-year renewal options. Derby Facility - On August 3, 2018, the Company purchased a medical office building located in Derby, Kansas for a purchase price of $3.6 million. Upon the closing of this acquisition, the Company assumed the existing lease with Rock Surgery Center, LLC. The lease has approximately nine years remaining in its initial term, with one five-year tenant renewal option. The following table presents the details of the tangible and intangible assets acquired and liabilities assumed: Land and site improvements $ 566 Building and tenant improvements 2,585 In-place leases 299 Above market lease intangibles Leasing costs 154 Below market lease intangibles (23 ) Total purchase price $ 3,581 Intangible Assets and Liabilities The following is a summary of the carrying amount of intangible assets and liabilities as of the dates presented: As of September 30, 2018 Cost Accumulated Amortization Net Assets In-place leases $ 21,171 $ (3,374 ) $ 17,797 Above market ground lease 707 (22 ) 685 Above market leases 7,381 (840 ) 6,541 Leasing costs 12,394 (1,386 ) 11,008 $ 41,653 $ (5,622 ) $ 36,031 Liabilities Below market leases $ 2,284 $ (250 ) $ 2,034 As of December 31, 2017 Cost Accumulated Amortization Net Assets In-place leases $ 17,061 $ (1,577 ) $ 15,484 Above market ground lease 488 (6 ) 482 Above market leases 4,625 (220 ) 4,405 Leasing costs 9,476 (538 ) 8,938 $ 31,650 $ (2,341 ) $ 29,309 Liabilities Below market leases $ 1,389 $ (98 ) $ 1,291 The following is a summary of the acquired lease intangible amortization: Three Months Ended September 30, Nine Months Ended September 30, 2018 2017 2018 2017 Amortization expense related to in-place leases $ 647 $ 388 $ 1,797 $ 1,022 Amortization expense related to leasing costs $ 307 $ 135 $ 848 $ 304 Decrease in rental revenue related to above market ground lease $ 6 $ 2 $ 16 $ 4 Decrease in rental revenue related to above market leases $ 240 $ 55 $ 620 $ 73 Increase in rental revenue related to below market leases $ 56 $ 32 $ 152 $ 63 As of September 30, 2018, scheduled future aggregate net amortization of the acquired lease intangible assets and liabilities for each fiscal year ended December 31 is listed below: Net Decrease in Revenue Net Increase in Expenses 2018 (three months remaining) $ (189 ) $ 958 2019 (653 ) 3,722 2020 (602 ) 3,668 2021 (605 ) 3,053 2022 (606 ) 2,744 Thereafter (2,537 ) 14,660 Total $ (5,192 ) $ 28,805 As of September 30, 2018, the weighted average amortization periods for asset lease intangibles and liability lease intangibles were 7.49 years and 9.02 years, respectively.

Notes Payable and Revolving Cre

Notes Payable and Revolving Credit Facility	9 Months Ended
	Sep. 30, 2018
Debt Disclosure [Abstract]
Debt Disclosure [Text Block]	Note 4 – Notes Payable and Revolving Credit Facility Summary of Notes Payable, Net of Discount The Company’s notes payable, net, includes two loans: (1) the Cantor Loan and (2) the West Mifflin Note, described below. The following table sets forth the aggregate balances of these loans as of the dates presented: September 30, 2018 December 31, 2017 Notes payable, gross $ 39,475 $ 39,475 Less: Unamortized debt discount (832 ) (930 ) Notes payable, net $ 38,643 $ 38,545 Costs incurred related to securing these debt instruments were capitalized as a debt discount, net of accumulated amortization, and are netted against the Company’s “Notes Payable Net of Unamortized Discount” balance in the accompanying Consolidated Balance Sheets. Amortization expense incurred related to the debt discount was $33 and $98 for the three and nine months ended September 30, 2018, respectively, and $33 and $98 for the three and nine months ended September 30, 2017, respectively, and is included in the “Interest Expense” line item in the accompanying Consolidated Statements of Operations. Cantor Loan On March 31, 2016, through certain of its wholly owned subsidiaries, the Company entered into a $32,097 portfolio commercial mortgage-backed securities loan (the “Cantor Loan”) with Cantor Commercial Real Estate Lending, LP (“CCRE”). The subsidiaries are GMR Melbourne, LLC, GMR Westland, LLC, GMR Memphis, LLC, and GMR Plano, LLC (the “GMR Loan Subsidiaries”). The Cantor Loan has cross-default and cross-collateral terms. The Cantor Loan has a maturity date of April 6, 2026 and accrues annual interest at 5.22%. The first five years of the term require interest-only payments and thereafter payments will include interest and principal, amortized over a 30-year schedule. Prepayment can only occur within four months prior to the maturity date, except that after the earlier of (a) two years after the loan is placed in a securitized mortgage pool, or (b) May 6, 2020, the Cantor Loan can be fully and partially defeased upon payment of amounts due under the Cantor Loan and payment of a defeasance amount that is sufficient to purchase U.S. government securities equal to the scheduled payments of principal, interest, fees, and any other amounts due related to a full or partial defeasance under the Cantor Loan. The Company secured the payment of the Cantor Loan with the assets, including property, facilities, and rents, held by the GMR Loan Subsidiaries and has agreed to guarantee certain customary recourse obligations, including findings of fraud, gross negligence, or breach of environmental covenants by the GMR Loan Subsidiaries. The GMR Loan Subsidiaries will be required to maintain a monthly debt service coverage ratio of 1.35:1.00 for all of the collateral properties in the aggregate. The note balance as of September 30, 2018 and December 31, 2017 was $32,097. I nterest expense incurred on this note was $428 and $1,271 for the three and nine months ended September 30, 2018, respectively, and $428 and $1,271 for the three and nine months ended September 30, 2017, respectively. As of September 30, 2018, scheduled principal payments due for each fiscal year ended December 31 are listed below as follows: 2018 $ - 2019 - 2020 - 2021 315 2022 449 Thereafter 31,333 Total $ 32,097 West Mifflin Note On September 25, 2015 the Company (through its wholly-owned subsidiary GMR Pittsburgh LLC, as borrower) entered into a Term Loan and Security Agreement with Capital One to borrow $7,378. The note bears interest at 3.72% per annum and all unpaid interest and principal is due on September 25, 2020. Interest is paid in arrears and interest payments began on November 1, 2015, and on the first day of each calendar month thereafter. Principal payments begin on November 1, 2018 and on the first day of each calendar month thereafter based on an amortization schedule with the remaining principal balance due on the maturity date. The Company, at its option, may prepay the note at any time, in whole (but not in part) with advanced written notice. The note has an early termination fee of two percent if prepaid prior to September 25, 2018. The West Mifflin facility serves as collateral for the note. The note requires a quarterly fixed charge coverage ratio of at least 1:1, a quarterly minimum debt yield of 0.09:1.00, and annualized Operator EBITDAR (as defined in the note) measured on a quarterly basis of not less than $6,000. The Operator is Associates in Ophthalmology, Ltd. and Associates Surgery Centers, LLC. The note balance as of September 30, 2018 and December 31, 2017 was $7,378. I nterest expense incurred on this note was $72 and $211 for the three and nine months ended September 30, 2018, respectively, and $70 and $209 for the three and nine months ended September 30, 2017, respectively. As of September 30, 2018, scheduled principal payments due for each fiscal year ended December 31 are listed below as follows: 2018 (three months remaining $ 22 2019 136 2020 7,220 Total $ 7,378 Credit Facility The Company, the Operating Partnership, as borrower, and certain of its subsidiaries (such subsidiaries, the “Subsidiary Guarantors”) are parties to a syndicated revolving credit facility with BMO Harris Bank N.A. (“BMO”), as Administrative Agent (the “Credit Facility). On August 7, 2018, the Company amended and restated the Credit Facility to (i) increase the overall capacity of the facility from $340 million to $350 million, consisting of a $250 million revolving credit facility (the “Revolver”) and a $100 million, five-year term loan (the “Term Loan”), (ii) extend the term of the Revolver to August 2022, with a one-year extension option, and (iii) implement a new reduced interest rate pricing matrix. The Credit Facility includes an accordion feature to increase the capacity to an aggregate of $500 million. Additionally, the Company hedged its interest rate risk on the Term Loan by entering into an interest rate swap agreement, with a notional amount of $100 million and a term of five years, which effectively fixed the LIBOR component on the Term Loan at 2.88%. For additional information related to the interest rate swap agreement see the “Interest Rate Swap Agreement” section herein. The following table presents the pricing matrix for the Revolver and the Term Loan: Total Leverage Ratio Revolver LIBOR Margin Revolver Base Rate Margin Term Loan LIBOR Margin Term Loan Base Rate Margin ≤ 45 1.40 % 0.40 % 1.35 % 0.35 % › 45 50 1.65 % 0.65 % 1.60 % 0.60 % › 50 55 1.90 % 0.90 % 1.85 % 0.85 % › 55 2.15 % 1.15 % 2.10 % 1.10 % The Subsidiary Guarantors and the Company are guarantors of the obligations under the Credit Facility. The amount available to borrow from time to time under the Credit Facility is limited according to a quarterly borrowing base valuation of certain properties owned by the Subsidiary Guarantors. The Operating Partnership is subject to ongoing compliance with a number of customary affirmative and negative covenants, including limitations with respect to liens, indebtedness, distributions, mergers, consolidations, investments, restricted payments and asset sales. The Operating Partnership must also maintain (i) a maximum consolidated leverage ratio as of the end of each fiscal quarter of less than (y) 0.65:1.00 for each fiscal quarter ending prior to October 1, 2019 and (z) thereafter, 0.60:1.00, (ii) a minimum fixed charge coverage ratio of 1.50:1.00, (iii) a minimum net worth of $203,795 plus 75% of all net proceeds raised through subsequent equity offerings and (iv) a ratio of total secured recourse debt to total asset value of not greater than 0.10:1.00. During the nine months ended September 30, 2018, the Company borrowed $142,900 under the Credit Facility (including the Term Loan) and repaid $10,400 for a net amount borrowed of $132,500. During the nine months ended September 30, 2017 the Company borrowed $205,400 under the Credit Facility and repaid $107,000 for a net amount borrowed of $98,400. I nterest expense incurred on the Credit Facility was $3,211 and $7,872 for the three and nine months ended September 30, 2018, respectively (including interest expense incurred on the Term Loan) and $1,336 and $2,946 for the three and nine months ended September 30, 2017, respectively. As of September 30, 2018 and December 31, 2017, the Company had the following outstanding borrowings under the Credit Facility: September 30, 2018 December 31, 2017 Revolver $ 197,400 $ 164,900 Term Loan 100,000 - Less: Unamortized deferred financing costs (4,127 ) (2,750 ) Credit Facility, net $ 293,273 $ 162,150 Costs incurred related to modifying the Credit Facility, net of accumulated amortization, and are netted against the Company’s “Revolving Credit Facility, Net of Unamortized Discount” balance in the accompanying Consolidated Balance Sheets. The Company paid $2,750 of costs related to modifications to the Credit Facility as well as fees incurred related to adding properties to the borrowing base during the nine months ended September 30, 2018. Amortization expense incurred was $455 and $1,373 for the three and nine months ended September 30, 2018, respectively, and $308 and $742 for the three and nine months ended September 30, 2017, respectively, and is included in the “Interest Expense” line item in the accompanying Consolidated Statements of Operations. Derivative Instrument - Interest Rate Swap To manage the interest rate risk related to the Term Loan, on August 7, 2018 the Company executed an interest rate swap with BMO that was designated as a cash flow hedge, with a notional amount of $100 million, a fixed interest rate of 2.88%, and a maturity date of August 8, 2023 The Company’s interest rate swap is not traded on an exchange. The Company’s interest rate swap agreement is recorded at fair value based on a variety of observable inputs including contractual terms, interest rate curves, yield curves, measure of volatility, and correlations of such inputs. The Company measures its derivatives at fair value on a recurring basis based on the expected size of future cash flows on a discounted basis and incorporating a measure of non-performance risk. The fair values are based on Level 2 inputs within the framework of ASC Topic 820, “Fair Value Measurement.” The Company considers its own credit risk, as well as the credit risk of its counterparty, when evaluating the fair value of its derivative instruments. The fair value of the Company’s interest rate swap agreement was $139 and zero as of September 30, 2018 and December 31, 2017, respectively. This amount is included in “Other Assets” on the Company’s Consolidated Balance Sheet as of September 30, 2018. The table below details the components of the loss presented on the accompanying Consolidated Statements of Comprehensive Income (Loss) recognized on the Company’s interest rate swap agreement designated as a cash flow hedge for the three and nine months ended September 30, 2018 and 2017: Three Months Ended September 30, Nine Months Ended September 30, 2018 2017 2018 2017 Amount of loss recognized in other comprehensive loss $ 122 $ - $ 122 $ - Amount of loss reclassified from accumulated other comprehensive loss into interest expense (13 ) - (13 ) - Total change in accumulated other comprehensive loss $ 109 $ - $ 109 $ - Weighted-Average Interest Rate and Term The weighted average interest rate and term of our debt was 4.35% and 4.46 years, respectively, at September 30, 2018, compared to 3.72% and 2.94 years, respectively, as of December 31, 2017.

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Sep. 30, 2018
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	Note 5 – Stockholders’ Equity Preferred Stock The Company’s charter authorizes the issuance of 10,000 shares of preferred stock, par value $0.001 per share. As of September 30, 2018 and December 31, 2017, there were 3,105 shares of Series A Cumulative Redeemable Preferred Stock (“Series A Preferred Stock”), issued and outstanding. The Series A Preferred Stock has a liquidation preference of $25 per share. Dividend activity on our preferred stock for the nine months ended September 30, 2018 is summarized in the following table: Date Announced Record Date Applicable Quarter Payment Date Quarterly Dividend Amount Accrued Dividends per Share December 15, 2017 January 15, 2018 Q4 2017 January 31, 2018 $ 1,455 $ - $ 0.46875 March 7, 2018 April 15, 2018 Q1 2018 April 30, 2018 $ 1,456 $ - $ 0.46875 June 15, 2018 July 15, 2018 Q2 2018 July 31, 2018 $ 1,455 $ - $ 0.46875 September 10, 2018 October 15, 2018 Q3 2018 October 31, 2018 $ 1,455 $ 970 1 $ 0.46875 (1) the accrued portion of the second quarter 2018 dividend as of September 30, 2018. The holders of the Series A Preferred Stock are entitled to receive dividend payments only when, as and if declared by the Board (or a duly authorized committee of the Board). Dividends will accrue or be payable in cash from the original issue date, on a cumulative basis, quarterly in arrears on each dividend payment date at a fixed rate per annum equal to 7.50% of the liquidation preference of $25 per share (equivalent to $1.875 per share on an annual basis). Dividends on the Series A Preferred Stock will be cumulative and will accrue whether or not (i) funds are legally available for the payment of those dividends, (ii) the Company has earnings or (iii) those dividends are declared by the Board. The quarterly dividend payment dates on the Series A Preferred Stock are January 31, April 30, July 31 and October 31 of each year, which commenced on October 31, 2017. During the nine months ended September 30, 2018, the Company paid preferred dividends of $4,366. No preferred dividends were paid during the three and nine months ended September 30, 2017. Common Stock The Company has 500,000 authorized shares of common stock, $0.001 par value. As of September 30, 2018 and December 31, 2017, there were 22,003 and 21,631 outstanding shares of common stock, respectively. On August 17, 2018, the Company, its Advisor, and the Operating Partnership entered into a Sales Agreement with a number of financial institutions, pursuant to which the Company may offer and sell, from time to time, up to $50 million of its common stock (the “ATM Program”), inclusive of any amounts sold under its prior sales agreement. During the three months ended September 30, 2018, pursuant to the ATM Program, the Company sold and issued 372 shares of its common stock for net proceeds of $3,209, which represented gross proceeds of $3,505 net of commissions of $53 and $243 in costs that the Company paid that were directly attributable to the offering under the ATM Program ($59 of costs directly attributable to the offering were accrued at September 30, 2018) . Common stock dividend activity for the nine months ended September 30, 2018 is summarized in the following table: Date Announced Record Date Applicable Quarter Payment Date Aggregate Dividend ‎ Amount (1) Dividends per Share December 15, 2017 December 26, 2017 Q4 2017 January 10, 2018 $ 4,552 $ 0.20 March 7, 2018 March 22, 2018 Q1 2018 April 10, 2018 $ 4,691 $ 0.20 June 15, 2018 June 26, 2018 Q2 2018 July 11, 2018 $ 4,786 $ 0.20 September 10, 2018 September 20, 2018 Q3 2018 October 10, 2018 $ 4,889 $ 0.20 (1) During the nine months ended September 30, 2018 and 2017, the Company paid total dividends on its common stock, LTIP units and OP Units in the aggregate amount of $14,075 and $10,815, respectively. As of September 30, 2018 and December 31, 2017, the Company had an accrued dividend balance of $250 and $116 for dividends payable on the aggregate annual and long-term LTIP units that are subject to retroactive receipt of dividends on the amount of LTIP units ultimately earned. During the nine months ended September 30, 2018, $180 of dividends were accrued and $46 of dividends were paid. During the nine months ended September 30, 2017, $92 of dividends were accrued and zero were paid. The amount of the dividends paid to the Company’s stockholders is determined by the Company’s Board and is dependent on a number of factors, including funds available for payment of dividends, the Company’s financial condition and capital expenditure requirements except that, in accordance with the Company’s organizational documents and Maryland law, the Company may not make dividend distributions that would: (i) cause it to be unable to pay its debts as they become due in the usual course of business; (ii) cause its total assets to be less than the sum of its total liabilities plus senior liquidation preferences; or (iii) jeopardize its ability to maintain its qualification as a REIT. OP Units During the nine months ended September 30, 2018, the Company issued 611 OP Units with a value of $4,742 in connection with a facility acquisition. During the year ended December 31, 2017, the Company issued 1,246 OP Units with a value of $11,532 primarily in connection with two facility acquisitions. As of September 30, 2018 and December 31, 2017, there were 1,857 and 1,246 OP Units issued, respectively, with an aggregate value of $16,274 and $11,532, respectively. The OP Unit value is included as a component of noncontrolling interest equity in the Company’s Consolidated Balance Sheets as of September 30, 2018 and December 31, 2017.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2018
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	Note 6 – Related Party Transactions Management Agreement Upon completion of the Company’s initial public offering on July 1, 2016, the Company and the Advisor entered into an amended and restated management agreement (the “Management Agreement”). Certain material terms of the Management Agreement are summarized in the section titled “ Business — Our Advisor and our Management Agreement ,” contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017 filed with the SEC on March 12, 2018. Management Fees and Accrued Management Fees The Company’s management fee to the Advisor is calculated in accordance with the terms of the Management Agreement which requires an annual base management fee equal to 1.5% of our stockholders’ equity (as defined in the Management Agreement). For the three and nine months ended September 30, 2018, management fees of $1,104 and $3,280, respectively, were incurred and expensed by the Company and during the nine months ended September 30, 2018, the Company paid management fees to the Advisor in the amount of $3,239. For the three and nine months ended September 30, 2017, management fees of $804 and $2,059, respectively, were incurred and expensed by the Company and during the nine months ended September 30, 2017, the Company paid management fees to the Advisor in the amount of $1,876. Accrued management fees due to the Advisor were $1,105 and $1,064 as of September 30, 2018 and December 31, 2017, respectively. No incentive management fee was incurred by the Company during the three and nine months ended September 30, 2018 or September 30, 2017, respectively. Allocated General and Administrative Expenses Effective May 8, 2017, the Company and the Advisor entered into an agreement pursuant to which, for a period of one year commencing on May 8, 2017, the Company agreed to reimburse the Advisor for $125 of the annual salary of the General Counsel and Secretary of the Company for so long as he continues to be primarily dedicated to the Company in his capacity as its General Counsel and Secretary. This agreement expired in May 2018 and was not renewed. In the future, the Company may receive additional allocations of general and administrative expenses from the Advisor that are either clearly applicable to or were reasonably allocated to the operations of the Company. Other than via the terms of the reimbursement agreement, there were no allocated general and administrative expenses from the Advisor for the three and nine months ended September 30, 2018 and September 30, 2017. Due to Related Parties, Net All related party balances are due on demand and non-interest-bearing. A rollforward of the due (to) from related parties balance, net, as of September 30, 2018, is as follows: Due to Advisor – Mgmt. Fees Due (to) from Advisor – Other Funds Due (to) from Other Related Party Total Due (To) From Related Parties, Net Balance as of January 1, 2018 $ (1,064 ) 9 19 $ (1,036 ) Management fee expense incurred (1) (3,280 ) - - (3,280 ) Management fees paid to Advisor (1) 3,239 - - 3,239 Loans to Advisor (2) - 9 - 9 Loans to other related parties (2) - - 40 40 Balance as of September 30, 2018 $ (1,105 ) 18 59 (1,028 ) (1) (2)

Stock-Based Compensation

Stock-Based Compensation	9 Months Ended
	Sep. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	Note 7 – Stock-Based Compensation 2016 Equity Incentive Plan The 2016 Equity Incentive Plan (the “Plan”) is intended to assist the Company and its affiliates in recruiting and retaining employees of the Manager, members of the Board, executive officers of the Company, and individuals who provide services to those entities or affiliates of those entities. The Plan is intended to permit the grant of both qualifying and non-qualified options and the grant of stock appreciation rights, restricted stock, unrestricted stock, awards of restricted stock units, performance awards and other equity-based awards (including LTIP units) for up to an aggregate of 1,232 shares of common stock, subject to increase under certain provisions of the Plan. Based on the grants outstanding as of September 30, 2018, there are 277 units that remain available to be granted under the Plan. Units subject to awards under the Plan that are forfeited, cancelled, lapsed, settled in cash or otherwise expired (excluding shares withheld to satisfy exercise prices or tax withholding obligations) are available for grant. Time-Based Grants The time-based vesting LTIP unit activity under the Plan during the nine months ended September 30, 2018 was as follows: LTIP units outstanding as of December 31, 2017 436 LTIP units granted (1) 57 LTIP units earned and granted via the 2017 performance program – Annual Awards (2) 57 LTIP units granted as 2018 time-based awards (3) 73 LTIP units redeemed in cash or forfeited (4) (35 ) LTIP units outstanding as of September 30, 2018 588 (1) The 57 LTIP units are comprised of the following: on March 5, 2018, the Board approved grants of an aggregate of 36 LTIP Units to employees of the Advisor, which vest 50% on March 5, 2020 and 50% on March 5, 2021; on May 30, 2018 and June 14, 2018 the Board approved grants of an aggregate of 21 LTIP Units to independent directors of the Board, which vest on May 30, 2019 and June 14, 2019. (2) The 57 LTIP units represents earned and granted units from the previously disclosed 2017 annual awards (the “Annual Awards”). On March 5, 2018 the Compensation Committee of the Board (the “Compensation Committee”) determined the extent to which the Company achieved the performance goals related to the 2017 Annual Awards and determined the number of LTIP units that each grantee was entitled to receive. These grants vested 50% on March 5, 2018, the determination date, and 50% vest on December 31, 2018. (3) The 73 LTIP units represent grants approved by the Board on March 5, 2018 and are subject to the terms and conditions of the 2018 LTIP Unit Award Agreements between the Company and each grantee. These grants vest in equal one-third increments on each of March 5, 2019, March 5, 2020, and March 5, 2021. (4) The 35 LTIP units is comprised of 34 vested units that the Company elected to redeem in cash for $263 and the remaining unvested unit was forfeited. A detail of the vested and unvested LTIP units outstanding as of September 30, 2018 is as follows: Total vested units 285 Unvested units: Granted to employees of the Advisor 282 Granted to the Company’s independent directors 21 Total unvested units 303 LTIP units outstanding as of September 30, 2018 588 Performance Based Awards During 2017, the Board approved the 2017 annual performance-based equity incentive awards in the form of LTIP units and long-term performance-based LTIP awards to the executive officers of the Company and other employees of the Advisor who perform services for the Company (the “2017 Program”). During the nine months ended September 30, 2018, the Board approved the 2018 annual performance-based equity incentive awards in the form of LTIP units and long-term performance-based LTIP awards to the executive officers of the Company and other employees of the Advisor who perform services for the Company (the “2018 Program”). None of the long-term LTIP unit awards under the 2017 Program and none of the annual or long-term LTIP unit awards under the 2018 Program had been earned by the participants as of September 30, 2018. A detail of the Annual Awards and the long-term awards (the “Long-Term Awards”) under the 2017 Program and the 2018 Program as of September 30, 2018 is as follows: 2017 Program 2018 Program Annual Long- Term Annual Long- Term Total Net 2017 Program LTIP awards as of December 31, 2017 84 98 - - 182 LTIP unit target grants via the 2018 Performance Program – Long-Term Awards (1) - - - 110 110 LTIP unit target grants via the 2018 Performance Program – Annual Awards (2) - - 163 - 163 LTIP units granted via the 2017 Performance Program – Annual Awards (3) (57 ) - - - (57 ) LTIP units not earned under the 2017 Performance Program – Annual Awards (4) (27 ) - - - (27 ) LTIP unit forfeitures (5) (2 ) (2 ) (4 ) Net annual and long-term LTIP awards as of September 30, 2018 - 96 161 110 367 (1) These target Long-Term Awards were approved by the Board on March 5, 2018 and are subject to the terms and conditions of the 2018 LTIP Unit Award Agreements between the Company and each grantee. (2) These target Annual Awards were approved by the Board on April 9, 2018 and are subject to the terms and conditions of the 2018 LTIP Unit Award Agreements between the Company and each grantee. (3) This amount represents grants from the 2017 Program Annual Awards. Refer to the “Time-Based Grants” table above which presents these grants as earned and time-based. (4) On March 5, 2018 the Compensation Committee determined the extent to which the Company achieved the performance goals and concluded that these target awards were not earned. (5) Represents LTIP units forfeited by grantee. The number of target LTIP units comprising each 2018 Program Annual Award target grant was based on the closing price of the Company’s common stock reported on the New York Stock Exchange (“NYSE”) on the dates of grant. The number of target LTIP units comprising each Long-Term Award target grant was based on the fair value of the Long-Term Awards as determined by an independent valuation consultant, in each case rounded to the next whole LTIP unit in order to eliminate fractional units. Annual Awards . The Annual Awards are subject to the terms and conditions of LTIP Annual Award Agreements (“LTIP Annual Award Agreements”) between the Company and each grantee. The Compensation Committee and Board established performance goals for calendar year 2018, as set forth in Exhibit A to the 2018 LTIP Annual Award Agreements (the “Performance Goals”) that will be used to determine the number of LTIP units earned by each grantee. As of September 30, 2018, management estimated that the Performance Goals would be met at a 75% level, and accordingly, applied 75% to the net target 2018 Program Annual Awards to estimate the 2018 Program Annual Awards expected to be earned at the end of the performance period. Cumulative stock-based compensation expense during the nine months ended September 30, 2018 reflects management’s estimate that 75% of these awards will vest. As soon as reasonably practicable following the last day of the 2018 fiscal year, the Compensation Committee and Board will determine the extent to which the Company has achieved each of the Performance Goals (expressed as a percentage) and, based on such determination, will calculate the number of LTIP units that each grantee is entitled to receive. Each grantee may earn up to 150% of the number of his/her target LTIP units. Any 2018 Annual Award LTIP units that are not earned will be forfeited and cancelled. Vesting. LTIP units that are earned as of the end of the applicable performance period will be subject to vesting, subject to continued employment through each vesting date, in two installments as follows: 50% of the earned LTIP units will become vested as of the earlier of (a) the date in 2019 that the Board approves the number of LTIP units to be awarded pursuant to the performance components set forth in the 2018 LTIP Annual Award Agreements, or (b) the date upon which a change of control occurs; and 50% of the Earned LTIP Units become vested on the one year anniversary of the initial vesting date. Distributions. Distributions equal to the dividends declared and paid by the Company will accrue during the applicable performance period on the maximum number of LTIP units that the grantee could earn and will be paid with respect to all of the earned LTIP units at the conclusion of the applicable performance period, in cash or by the issuance of additional LTIP units at the discretion of the Compensation Committee. Long-Term Awards. The Long-Term Awards are subject to the terms and conditions of 2017 and 2018 LTIP Long-Term Award Agreements (collectively the “LTIP Long-Term Award Agreements”) between the Company and each grantee. The number of LTIP units that each grantee is entitled to earn under the LTIP Long-Term Award Agreements will be determined following the conclusion of a three-year performance period based on the Company’s total stockholder return (“TSR”), which is determined based on a combination of appreciation in stock price and dividends paid during the performance period. Each grantee may earn up to 200% of the number of target LTIP units covered by the grantee’s Long-Term Award. Any target LTIP units that are not earned will be forfeited and cancelled. The number of LTIP units earned under the Long-Term Awards will be determined as soon as reasonably practicable following the end of the three-year performance period (2020 or 2021 depending on the program) based on the Company’s TSR on an absolute basis (as to 75% of the Long-Term Award) and relative to the SNL Healthcare REIT Index (as to 25% of the Long-Term Award). Vesting. LTIP units that are earned as of the end of the applicable performance period will be subject to forfeiture restrictions that will lapse (“vesting”), subject to continued employment through each vesting date as follows; for the 2017 Program units: 50% of the earned LTIP units will vest upon being earned as of February 27, 2020, or the date of a change of control, and the remaining 50% will vest on February 27, 2021; for the 2018 Program units: 50% of the earned LTIP units will vest upon being earned as of March 4, 2021, or the date of a change of control, and the remaining 50% will vest on March 4, 2022. Distributions. Pursuant to the LTIP Long-Term Award Agreements, distributions equal to the dividends declared and paid by the Company will accrue during the applicable performance period on the maximum number of LTIP units that the grantee could earn and will be paid with respect to all of the earned LTIP units at the conclusion of the applicable performance period, in cash or by the issuance of additional LTIP units at the discretion of the Compensation Committee. Stock-Based Compensation Expense In June 2018, the FASB issued ASU 2018-07, “Improvements to Nonemployee Share-Based Payment Accounting” (“ASU 2018-07”). ASU 2018-07 simplifies several aspects of the accounting for non-employee transactions by stipulating that the existing accounting guidance for share-based payments to employees (accounted for under ASC Topic 718, “Compensation-Stock Compensation”) will also apply to non-employee share-based transactions (accounted for under ASC Topic 505, “Equity”). ASU 2018-07 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. The Company early adopted ASU 2018-07 on July 1, 2018 and the adoption did not have a material impact on its consolidated financial statements or disclosures. Under the provisions of ASU 2018-07 the Company’s prospective compensation expense for all unvested LTIP units, Annual Awards, and Long-Term Awards will be recognized using the adoption date fair value of the awards, with no remeasurement required. Compensation expense for future LTIP unit grants, Annual Awards, and Long-Term Awards will be based on the grant date fair value of the units / awards, with no subsequent remeasurement required. The Company incurred stock compensation expense of $741 and $1,978 for the three and nine months ended September 30, 2018, respectively, and $340 and $1,481 for the three and nine months ended September 30, 2017, respectively, related to the grants awarded under the Plan. Compensation expense is included within “General and Administrative” expense in the Company’s Consolidated Statements of Operations. As of September 30, 2018, total unamortized compensation expense related to these awards of approximately $3,567 is expected to be recognized over a weighted average remaining period of 2.17 years.

Rental Revenue

Rental Revenue	9 Months Ended
	Sep. 30, 2018
Leases [Abstract]
Operating Leases of Lessor Disclosure [Text Block]	Note 8 – Rental Revenue The aggregate annual minimum cash to be received by the Company on the noncancelable operating leases related to its portfolio of facilities in effect as of September 30, 2018, is as follows for the subsequent years ended December 31: 2018 (three months remaining) $ 11,958 2019 48,111 2020 48,947 2021 47,342 2022 46,284 Thereafter 369,036 Total $ 571,678 The concentration of rental revenue for the three and nine months ended September 30, 2018 and 2017 is as follows: Three Months Ended September 30, Nine Months Ended September 30, Facility 2018 2017 2018 2017 Encompass 11 % 18 % 12 % 22 % Belpre 11 - 7 - OCOM 9 15 10 12 Sherman 6 10 6 - Austin 6 - 7 - East Dallas 6 - 5 - Great Bend 4 8 5 7 Omaha 3 6 4 7 Plano 3 5 3 6 Tennessee 3 - 3 6 Aggregate of all other facilities (1) 38 38 38 40 Total 100 % 100 % 100 % 100 % (1) None individually greater than 3% for the 2018 periods and none greater than 5% for the 2017 periods.

Land Leases

Land Leases	9 Months Ended
	Sep. 30, 2018
Leases [Abstract]
Leases of Lessee Disclosure [Text Block]	Note 9 – Land Leases The Company acquired an interest, as ground lessee, in the ground lease related to the Omaha and Clermont facilities at their dates of acquisition. In connection with the acquisitions of the Moline facility on January 24, 2018, the Company acquired the seller’s interest, as ground lessee, in an existing ground lease that has approximately 10 years remaining in the initial term, with 12 consecutive five-year renewal options. Additionally, in connection with the acquisition of the Silvis facility on January 24, 2018, the Company acquired the seller’s interest, as ground lessee, in an existing ground lease that has approximately 67 years remaining in the initial term, with no renewal options. The aggregate minimum cash payments to be made by the Company on these land leases in effect as of September 30, 2018, are as follows for the subsequent years ended December 31: 2018 (three months remaining) $ 27 2019 109 2020 109 2021 109 2022 109 Thereafter 2,234 Total $ 2,697

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2018
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	Note 10 – Commitments and Contingencies Litigation The Company is not presently subject to any material litigation nor, to its knowledge, is any material litigation threatened against the Company, which if determined unfavorably to the Company, would have a material adverse effect on the Company’s financial position, results of operations, or cash flows. Environmental Matters The Company follows a policy of monitoring its properties for the presence of hazardous or toxic substances. While there can be no assurance that a material environmental liability does not exist at its properties, the Company is not currently aware of any environmental liability with respect to its properties that would have a material effect on its financial position, results of operations, or cash flows. Additionally, the Company is not aware of any material environmental liability or any unasserted claim or assessment with respect to an environmental liability that management believes would require additional disclosure or the recording of a loss contingency.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2018
Subsequent Events [Abstract]
Subsequent Events [Text Block]	Note 11 – Subsequent Event On November 2, 2018, the Company entered into an agreement to sell its Great Bend Regional Hospital in Kansas for approximately $32 million.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2018
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of presentation The accompanying financial statements are unaudited and include the accounts of the Company, including the Operating Partnership and its wholly-owned subsidiaries. The accompanying financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and the rules and regulations of the United States Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures required for annual financial statements have been condensed or excluded pursuant to SEC rules and regulations. Accordingly, the accompanying financial statements do not include all of the information and footnotes required by GAAP for complete financial statements and should be read in conjunction with the audited financial statements and notes thereto for the fiscal year ended December 31, 2017. In the opinion of management, all adjustments of a normal and recurring nature necessary for a fair presentation of the financial statements for the interim periods have been made.
Consolidation, Policy [Policy Text Block]	Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company, including the Operating Partnership and its wholly-owned subsidiaries. The Company presents the portion of any equity it does not own but controls (and thus consolidates) as noncontrolling interest. Noncontrolling interest in the Company includes the LTIP units that have been granted to the Company’s and Advisor’s directors, officers and employees and the OP Units held by third parties. Refer to Note 5 – “Stockholders’ Equity” and Note 7 – “Stock-Based Compensation” for additional information regarding the LTIP units and OP Units. The Company classifies noncontrolling interest as a component of consolidated equity on its Consolidated Balance Sheets, separate from the Company’s total stockholders’ equity. The Company’s net income or loss is allocated to noncontrolling interests based on the respective ownership or voting percentage in the Operating Partnership associated with such noncontrolling interests and is removed from consolidated income or loss on the Consolidated Statements of Operations in order to derive net income or loss attributable to common stockholders. The noncontrolling ownership percentage is calculated by dividing the aggregate number of LTIP units and OP Units held by the total number of shares of common stock and units outstanding. Any future issuances of additional LTIP units or OP Units would change the noncontrolling ownership interest.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of the consolidated financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and footnotes. Actual results could differ from those estimates.
Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents and Restricted Cash On January 1, 2018 the Company adopted the provisions of Accounting Standards Update (“ASU”) 2016-18, “Statement of Cash Flows (Topic 230) Restricted Cash” (“ASU 2016-18”) , which requires that the statement of cash flows explain the change during the period in the total of cash and cash equivalents and amounts generally described as restricted cash. In accordance with the requirements of ASU 2016-18, the following table provides a reconciliation of the Company’s cash and cash equivalents and restricted cash that sums to the total of those amounts at the end of the periods presented on the Company’s accompanying Consolidated Statements of Cash Flows for the nine months ended September 30, 2018 and 2017: As of September 30, 2018 2017 Cash and cash equivalents $ 3,005 $ 6,777 Restricted cash 817 2,040 Total cash and cash equivalents and restricted cash (1) $ 3,822 $ 8,817 (1) Represents the total of the amounts at the end of the periods presented on the Consolidated Statements of Cash Flows as required by ASU 2016-18. The cash and cash equivalents and restricted cash balance as of December 31, 2017 and December 31, 2016 (the beginning balances of the periods presented) was $7,114 and $20,612, respectively. The Company considers all demand deposits, cashier’s checks, money market accounts, and certificates of deposit with a maturity of three months or less to be cash equivalents. Amounts included in restricted cash represent (1) certain security deposits received from tenants at the inception of their leases; (2) cash required to be held by a third-party lender as a reserve for debt service; and (3) funds held by the Company that were received from certain tenants that the Company collected to pay specific tenant expenses, such as real estate taxes and insurance, on the tenant’s behalf.
Receivables, Policy [Policy Text Block]	Tenant Receivables The tenant receivable balance as of September 30, 2018 and December 31, 2017 was $1,744 and $704, respectively. The balance as of September 30, 2018 consisted of $621 in funds owed from the Company’s tenants for rent that the Company had earned but had not yet received and $1,062 in funds owed by certain of the Company’s tenants for amounts the Company collects to pay specific tenant expenses, such as real estate taxes and insurance, on the tenants’ behalf. Additionally, as of September 30, 2018 the balance included $61 in miscellaneous receivables. The balance as of December 31, 2017 consisted of $125 in funds owed from the Company’s tenants for rent that the Company had earned but had not yet received, and $579 in funds owed by certain of the Company’s tenants for amounts the Company collects to pay specific tenant expenses, such as real estate taxes and insurance, on the tenants’ behalf.
Escrow Deposits [Policy Text Block]	Escrow Deposits The escrow balance as of September 30, 2018 and December 31, 2017 was $2,628 and $1,638, respectively. Escrow deposits include funds held in escrow to be used for the acquisition of properties in the future and for the payment of taxes, insurance, and other amounts as stipulated by the Company’s Cantor Loan, as hereinafter defined.
Deferred Assets [Policy Text Block]	Deferred Assets The deferred assets balance as of September 30, 2018 and December 31, 2017 was $8,590 and $3,993, respectively. The balance as of September 30, 2018 consisted of $7,813 in deferred rent receivables resulting from the recognition of revenue from leases with fixed annual rental escalations on a straight-line basis and the balance of $777 represented other deferred costs. The balance as of December 31, 2017 consisted of $3,842 in deferred rent receivables resulting from the recognition of revenue from leases with fixed annual rental escalations on a straight-line basis and the balance of $151 represented other deferred costs.
Other Assets [Policy Text Block]	Other Assets The other assets balance as of September 30, 2018 and December 31, 2017 was $1,109 and $459, respectively. The balance as of September 30, 2018 consisted primarily of $521 in construction-in-process related to tenant improvements (which was accrued and not paid as of September 30, 2018). Additionally, the balance included $180 in capitalized costs related to property acquisitions, $139 related to an interest rate swap asset (refer to the “Derivative Instrument – Interest Rate Swap” disclosure herein), and $269 in a prepaid asset. The balance as of December 31, 2017 consisted of $316 in capitalized costs related to property acquisitions and $143 in a prepaid asset.
Security Deposit Liability [Policy Text Block]	Security Deposits and Other The security deposits and other liability balance as of September 30, 2018 and December 31, 2017 was $3,928 and $2,128, respectively. The balance as of September 30, 2018 consisted of security deposits of $3,137 and a tenant impound liability of $791 related to amounts owed for specific tenant expenses, such as real estate taxes and insurance. The balance as of December 31, 2017 consisted of security deposits of $1,620 and a tenant impound liability of $508 related to amounts owed for specific tenant expenses.
Derivatives, Policy [Policy Text Block]	Derivative Instrument - Interest Rate Swap As disclosed in Note 4 – “Notes Payable and Revolving Credit Facility,” as of September 30, 2018, the Company had one interest rate swap derivative instrument that was designated as a cash flow hedge of interest rate risk. In accordance with the Company’s risk management strategy, the purpose of the interest rate swap is to manage interest rate risk for certain of the Company’s variable-rate debt. The interest rate swap involves the Company’s receipt of variable-rate amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreement. The Company accounts for derivative instruments in accordance with the provisions of Accounting Standards Codification (“ASC”) Topic 815, “Derivatives and Hedging.” Additionally, effective July 1, 2018, the Company adopted the provisions of Accounting Standards Update (“ASU”) No. 2017-12, “Derivatives and Hedging: Targeted Improvements to Accounting for Hedging Activities” (“ASU 2017-12”). The purpose of ASU 2017-12 is to better align a company’s financial reporting for hedging activities with the economic objectives of those activities. The adoption of ASU 2017-12 did not have a material impact on the Company’s consolidated financial statements or disclosures.
Reclassification, Policy [Policy Text Block]	Reclassification The Company reclassified the line item “Deferred Financing Costs, Net” on its Consolidated Balance Sheet as of December 31, 2017 to present this amount as a reduction of the Company’s “Revolving Credit Facility” liability balance. The deferred financing cost, net balance consists of costs incurred related to securing and amending the Company’s revolving credit facility (net of accumulated amortization). The reclassification was made to conform to the Company’s presentation of this line item in the Company’s Consolidated Balance Sheet as of September 30, 2018, which treats all unamortized deferred financing costs as a reduction of the debt balance.
New Accounting Pronouncements, Policy [Policy Text Block]	New Accounting Pronouncements Leases and Revenue Recognition In February 2016, the Financial Accounting Standards Board (FASB) issued ASU No. 2016-02 “Leases” (“ASU 2016-02”). This standard created Topic 842, Leases, and superseded FASB ASC Topic 840, “Leases.” ASU 2016-02 requires a lessee to recognize the assets and liabilities that arise from leases (both operating and finance leases). However, for leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election not to recognize lease assets and lease liabilities. The main difference between the existing guidance on accounting for leases and the new standard is that operating leases will now be recorded as assets and liabilities. The new standard requires lessors to account for leases using an approach that is substantially equivalent to existing guidance for operating leases. ASU 2016-02 is expected to impact the Company’s consolidated financial statements as the Company has certain operating ground lease arrangements for which it is the lessee and therefore will be required to recognize right of use assets and related lease liabilities on its consolidated balance sheets upon adoption of this new standard. Current GAAP requires only capital leases to be recognized on the balance sheet, and amounts related to operating leases largely are reflected in the financial statements as rent expense on the income statement and in notes to the financial statements. ASU 2016-02 is effective for annual reporting periods (including interim periods within those periods) beginning after December 15, 2018. Early adoption is permitted. Based on its anticipated election of the practical expedients, the Company anticipates that its leases where it is the lessor and several ground leases where the Company is the lessee will continue to be accounted for as operating leases under the new standard. Therefore, as of January 1, 2019, the Company does not currently anticipate significant changes in the accounting for its lease revenues and expenses. For the Company’s ground leases where it is the lessee, it will be required to recognize right of use assets and related lease liabilities on its consolidated balance sheets upon adoption. The Company will not be required to reassess the classification of existing leases where it is the lessor or existing ground leases where it is the lessee and therefore the leases would continue to be accounted for as operating leases. However, in the event the Company modifies existing leases or enters into new leases after adoption of the new standard, such leases may be classified as finance leases. The Company will continue to evaluate the impact of adopting the new leases standard on its consolidated statements of income and comprehensive income and consolidated balance sheets. In May 2014, with subsequent updates issued in August 2015 and March, April and May 2016, the FASB issued ASU 2014-09 “Revenue from Contracts with Customers (Topic 606)” (“ASU 2014-09”). ASU 2014-09 was developed to enable financial statement users to better understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The update’s core principle is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Companies are to use a five-step contract review model to ensure revenue is recognized, measured and disclosed in accordance with this principle. Those steps include the following: (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to each performance obligation in the contract, and (v) recognize revenue when or as the entity satisfies a performance obligation. The Company has identified four main revenue streams, three of which originate from lease contracts and will be subject to Leases ASU 2016-02, Topic 842 (described above) effective for annual reporting periods (including interim periods) beginning after December 15, 2018. The Company’s revenue streams are: Revenue Recognition (ASU 2014-09, Topic 610-20): (1) Gain (loss) on sale of real estate properties Leases (ASU 2016-02, Topic 842): (2) Rental revenues (3) Straight line rents (4) Tenant recoveries The Company adopted the provisions of ASU 2014-09 effective January 1, 2018 and concluded that all of the Company’s material revenue streams fall outside of the scope of this guidance. During the three and nine months ended September 30, 2018 and 2017, the Company sold no real estate properties and therefore had no revenue streams from that source. The new standard may be applied retrospectively to each prior period presented or prospectively with the cumulative effect, if any, recognized as of the date of adoption. The Company selected the modified retrospective transition method as of the date of adoption effective January 1, 2018. Management concluded that the majority of its total revenues consist of rental income from leasing arrangements, which is specifically excluded from the standard. The Company analyzed its remaining revenue streams and concluded there are no changes in revenue recognition with the adoption of the new standard. As such, adoption of ASU 2014-09 did not result in a cumulative adjustment recognized as of January 1, 2018, and the standard did not have a material impact on the Company’s consolidated financial statements or disclosures.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2018
Accounting Policies [Abstract]
Restrictions on Cash and Cash Equivalents [Table Text Block]	Consolidated Statements of Cash Flows for the nine months ended September 30, 2018 and 2017: As of September 30, 2018 2017 Cash and cash equivalents $ 3,005 $ 6,777 Restricted cash 817 2,040 Total cash and cash equivalents and restricted cash (1) $ 3,822 $ 8,817 (1) Represents the total of the amounts at the end of the periods presented on the Consolidated Statements of Cash Flows as required by ASU 2016-18. The cash and cash equivalents and restricted cash balance as of December 31, 2017 and December 31, 2016 (the beginning balances of the periods presented) was $7,114 and $20,612, respectively.

Property Portfolio (Tables)

Property Portfolio (Tables)	9 Months Ended
	Sep. 30, 2018
Property, Plant and Equipment [Table Text Block]	A rollforward of the gross investment in land, building and improvements as of September 30, 2018, resulting from these acquisitions is as follows: Land Building Site & Tenant Improvements Acquired Lease Intangibles Gross Investment in Real Estate Balances as of January 1, 2018 $ 42,701 $ 384,338 $ 12,818 $ 31,650 $ 471,507 Facility Acquired – Date Acquired: Moline / Silvis – 1/24/18 - 4,895 1,216 989 7,100 Freemont – 2/9/18 162 8,335 - - 8,497 Gainesville – 2/23/18 625 9,885 - - 10,510 Dallas – 3/1/18 6,272 17,012 - - 23,284 Orlando – 3/22/18 2,543 11,720 756 1,395 16,414 Belpre – 4/19/18 3,025 50,526 3,966 7,166 64,683 McAllen – 7/3/18 1,099 4,296 5,395 Derby – 8/3/18 412 2,496 243 453 3,604 Tenant improvements (1) - - 2,043 - 2,043 Total Additions (2) 14,138 109,165 8,224 10,003 141,530 Balances as of September 30, 2018 $ 56,839 $ 493,503 $ 21,042 $ 41,653 $ 613,037 (1) Represents tenant improvements that were completed and placed in service during the three months ended September 30, 2018 related to the Silvis and Sherman facilities that were acquired in January 2018 and June 2017, respectively. These amounts were recorded as construction-in-process within the “Other Assets” line item in the Company’s Consolidated Balance Sheet as of June 30, 2018, and reclassified to investment in real estate once completed. (2) The Belpre acquisition included $4,742 of OP Units issued as part of the total consideration for the transaction. As indicated in (1) above, $2,043 of completed construction-in-process costs were reclassified to investment in real estate during the three months ended September 30, 2018. Additionally, an aggregate of $894 of intangible liabilities were acquired from the acquisitions that occurred during the nine months ended September 30, 2018. Accordingly, the total addition to gross investment in real estate funded with cash was $133,851.
Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]	The following is a summary of the carrying amount of intangible assets and liabilities as of the dates presented: As of September 30, 2018 Cost Accumulated Amortization Net Assets In-place leases $ 21,171 $ (3,374 ) $ 17,797 Above market ground lease 707 (22 ) 685 Above market leases 7,381 (840 ) 6,541 Leasing costs 12,394 (1,386 ) 11,008 $ 41,653 $ (5,622 ) $ 36,031 Liabilities Below market leases $ 2,284 $ (250 ) $ 2,034 As of December 31, 2017 Cost Accumulated Amortization Net Assets In-place leases $ 17,061 $ (1,577 ) $ 15,484 Above market ground lease 488 (6 ) 482 Above market leases 4,625 (220 ) 4,405 Leasing costs 9,476 (538 ) 8,938 $ 31,650 $ (2,341 ) $ 29,309 Liabilities Below market leases $ 1,389 $ (98 ) $ 1,291
Finite-lived Intangible Assets Amortization Expense [Table Text Block]	The following is a summary of the acquired lease intangible amortization: Three Months Ended September 30, Nine Months Ended September 30, 2018 2017 2018 2017 Amortization expense related to in-place leases $ 647 $ 388 $ 1,797 $ 1,022 Amortization expense related to leasing costs $ 307 $ 135 $ 848 $ 304 Decrease in rental revenue related to above market ground lease $ 6 $ 2 $ 16 $ 4 Decrease in rental revenue related to above market leases $ 240 $ 55 $ 620 $ 73 Increase in rental revenue related to below market leases $ 56 $ 32 $ 152 $ 63
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	As of September 30, 2018, scheduled future aggregate net amortization of the acquired lease intangible assets and liabilities for each fiscal year ended December 31 is listed below: Net Decrease in Revenue Net Increase in Expenses 2018 (three months remaining) $ (189 ) $ 958 2019 (653 ) 3,722 2020 (602 ) 3,668 2021 (605 ) 3,053 2022 (606 ) 2,744 Thereafter (2,537 ) 14,660 Total $ (5,192 ) $ 28,805
Silvis Facilities [Member]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	The aggregate purchase price for the Moline/Silvis facilities was $6.9 million. The following table presents the details of the tangible and intangible assets acquired and liabilities assumed for this acquisition: Site improvements $ 249 Building and tenant improvements 5,862 In-place leases 343 Above market ground lease intangibles 219 Leasing costs 427 Below market lease intangibles (229 ) Total purchase price $ 6,871
Orlando Facilities [Member]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	The following table presents the details of the tangible and intangible assets acquired and liabilities assumed: Land and site improvements $ 3,075 Building and tenant improvements 11,944 In-place leases 808 Above market lease intangibles 229 Leasing costs 358 Below market lease intangibles (10 ) Total purchase price $ 16,404
Belpre Portfolio [Member]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	The following table presents the details of the tangible and intangible assets acquired and liabilities assumed: Land and site improvements $ 3,997 Building and tenant improvements 53,520 In-place leases 2,660 Above market lease intangibles 2,527 Leasing costs 1,979 Below market lease intangibles (632 ) Total purchase price $ 64,051
Derby Facility [Member]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	The following table presents the details of the tangible and intangible assets acquired and liabilities assumed: Land and site improvements $ 566 Building and tenant improvements 2,585 In-place leases 299 Above market lease intangibles Leasing costs 154 Below market lease intangibles (23 ) Total purchase price $ 3,581

Notes Payable and Revolving C_2

Notes Payable and Revolving Credit Facility (Tables)	9 Months Ended
	Sep. 30, 2018
Debt Instrument [Line Items]
Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]	The Company’s notes payable, net, includes two loans: (1) the Cantor Loan and (2) the West Mifflin Note, described below. The following table sets forth the aggregate balances of these loans as of the dates presented: September 30, 2018 December 31, 2017 Notes payable, gross $ 39,475 $ 39,475 Less: Unamortized debt discount (832 ) (930 ) Notes payable, net $ 38,643 $ 38,545
Schedule Of Pricing Matrix For Revolver And Term Loan [Table Text Block]	The following table presents the pricing matrix for the Revolver and the Term Loan: Total Leverage Ratio Revolver LIBOR Margin Revolver Base Rate Margin Term Loan LIBOR Margin Term Loan Base Rate Margin ≤ 45 1.40 % 0.40 % 1.35 % 0.35 % › 45 50 1.65 % 0.65 % 1.60 % 0.60 % › 50 55 1.90 % 0.90 % 1.85 % 0.85 % › 55 2.15 % 1.15 % 2.10 % 1.10 %
Schedule of Line of Credit Facilities [Table Text Block]	As of September 30, 2018 and December 31, 2017, the Company had the following outstanding borrowings under the Credit Facility: September 30, 2018 December 31, 2017 Revolver $ 197,400 $ 164,900 Term Loan 100,000 - Less: Unamortized deferred financing costs (4,127 ) (2,750 ) Credit Facility, net $ 293,273 $ 162,150
Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block]	The table below details the components of the loss presented on the accompanying Consolidated Statements of Comprehensive Income (Loss) recognized on the Company’s interest rate swap agreement designated as a cash flow hedge for the three and nine months ended September 30, 2018 and 2017: Three Months Ended September 30, Nine Months Ended September 30, 2018 2017 2018 2017 Amount of loss recognized in other comprehensive loss $ 122 $ - $ 122 $ - Amount of loss reclassified from accumulated other comprehensive loss into interest expense (13 ) - (13 ) - Total change in accumulated other comprehensive loss $ 109 $ - $ 109 $ -
Cantor Loan [Member]
Debt Instrument [Line Items]
Schedule of Maturities of Long-term Debt [Table Text Block]	As of September 30, 2018, scheduled principal payments due for each fiscal year ended December 31 are listed below as follows: 2018 $ - 2019 - 2020 - 2021 315 2022 449 Thereafter 31,333 Total $ 32,097
West Mifflin Note Payable [Member]
Debt Instrument [Line Items]
Schedule of Maturities of Long-term Debt [Table Text Block]	As of September 30, 2018, scheduled principal payments due for each fiscal year ended December 31 are listed below as follows: 2018 (three months remaining $ 22 2019 136 2020 7,220 Total $ 7,378

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	9 Months Ended
	Sep. 30, 2018
Common Stock [Member]
Schedule of Dividends Payable [Table Text Block]	Common stock dividend activity for the nine months ended September 30, 2018 is summarized in the following table: Date Announced Record Date Applicable Quarter Payment Date Aggregate Dividend ‎ Amount (1) Dividends per Share December 15, 2017 December 26, 2017 Q4 2017 January 10, 2018 $ 4,552 $ 0.20 March 7, 2018 March 22, 2018 Q1 2018 April 10, 2018 $ 4,691 $ 0.20 June 15, 2018 June 26, 2018 Q2 2018 July 11, 2018 $ 4,786 $ 0.20 September 10, 2018 September 20, 2018 Q3 2018 October 10, 2018 $ 4,889 $ 0.20
Preferred Stock [Member]
Schedule of Dividends Payable [Table Text Block]	Dividend activity on our preferred stock for the nine months ended September 30, 2018 is summarized in the following table: Date Announced Record Date Applicable Quarter Payment Date Quarterly Dividend Amount Accrued Dividends per Share December 15, 2017 January 15, 2018 Q4 2017 January 31, 2018 $ 1,455 $ - $ 0.46875 March 7, 2018 April 15, 2018 Q1 2018 April 30, 2018 $ 1,456 $ - $ 0.46875 June 15, 2018 July 15, 2018 Q2 2018 July 31, 2018 $ 1,455 $ - $ 0.46875 September 10, 2018 October 15, 2018 Q3 2018 October 31, 2018 $ 1,455 $ 970 1 $ 0.46875

Related Party Transactions (Tab

Related Party Transactions (Tables)	9 Months Ended
	Sep. 30, 2018
Related Party Transactions [Abstract]
Schedule of Related Party Transactions [Table Text Block]	A rollforward of the due (to) from related parties balance, net, as of September 30, 2018, is as follows: Due to Advisor – Mgmt. Fees Due (to) from Advisor – Other Funds Due (to) from Other Related Party Total Due (To) From Related Parties, Net Balance as of January 1, 2018 $ (1,064 ) 9 19 $ (1,036 ) Management fee expense incurred (1) (3,280 ) - - (3,280 ) Management fees paid to Advisor (1) 3,239 - - 3,239 Loans to Advisor (2) - 9 - 9 Loans to other related parties (2) - - 40 40 Balance as of September 30, 2018 $ (1,105 ) 18 59 (1,028 ) (1) (2)

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2018
Schedule of Share-based Compensation, Activity [Table Text Block]	The time-based vesting LTIP unit activity under the Plan during the nine months ended September 30, 2018 was as follows: LTIP units outstanding as of December 31, 2017 436 LTIP units granted (1) 57 LTIP units earned and granted via the 2017 performance program – Annual Awards (2) 57 LTIP units granted as 2018 time-based awards (3) 73 LTIP units redeemed in cash or forfeited (4) (35 ) LTIP units outstanding as of September 30, 2018 588 (1) The 57 LTIP units are comprised of the following: on March 5, 2018, the Board approved grants of an aggregate of 36 LTIP Units to employees of the Advisor, which vest 50% on March 5, 2020 and 50% on March 5, 2021; on May 30, 2018 and June 14, 2018 the Board approved grants of an aggregate of 21 LTIP Units to independent directors of the Board, which vest on May 30, 2019 and June 14, 2019. (2) The 57 LTIP units represents earned and granted units from the previously disclosed 2017 annual awards (the “Annual Awards”). On March 5, 2018 the Compensation Committee of the Board (the “Compensation Committee”) determined the extent to which the Company achieved the performance goals related to the 2017 Annual Awards and determined the number of LTIP units that each grantee was entitled to receive. These grants vested 50% on March 5, 2018, the determination date, and 50% vest on December 31, 2018. (3) The 73 LTIP units represent grants approved by the Board on March 5, 2018 and are subject to the terms and conditions of the 2018 LTIP Unit Award Agreements between the Company and each grantee. These grants vest in equal one-third increments on each of March 5, 2019, March 5, 2020, and March 5, 2021. (4) The 35 LTIP units is comprised of 34 vested units that the Company elected to redeem in cash for $263 and the remaining unvested unit was forfeited. A detail of the vested and unvested LTIP units outstanding as of September 30, 2018 is as follows: Total vested units 285 Unvested units: Granted to employees of the Advisor 282 Granted to the Company’s independent directors 21 Total unvested units 303 LTIP units outstanding as of September 30, 2018 588
Schedule of Stock Options Roll Forward [Table Text Block]	A detail of the Annual Awards and the long-term awards (the “Long-Term Awards”) under the 2017 Program and the 2018 Program as of September 30, 2018 is as follows: 2017 Program 2018 Program Annual Long- Term Annual Long- Term Total Net 2017 Program LTIP awards as of December 31, 2017 84 98 - - 182 LTIP unit target grants via the 2018 Performance Program – Long-Term Awards (1) - - - 110 110 LTIP unit target grants via the 2018 Performance Program – Annual Awards (2) - - 163 - 163 LTIP units granted via the 2017 Performance Program – Annual Awards (3) (57 ) - - - (57 ) LTIP units not earned under the 2017 Performance Program – Annual Awards (4) (27 ) - - - (27 ) LTIP unit forfeitures (5) (2 ) (2 ) (4 ) Net annual and long-term LTIP awards as of September 30, 2018 - 96 161 110 367 (1) These target Long-Term Awards were approved by the Board on March 5, 2018 and are subject to the terms and conditions of the 2018 LTIP Unit Award Agreements between the Company and each grantee. (2) These target Annual Awards were approved by the Board on April 9, 2018 and are subject to the terms and conditions of the 2018 LTIP Unit Award Agreements between the Company and each grantee. (3) This amount represents grants from the 2017 Program Annual Awards. Refer to the “Time-Based Grants” table above which presents these grants as earned and time-based. (4) On March 5, 2018 the Compensation Committee determined the extent to which the Company achieved the performance goals and concluded that these target awards were not earned. (5) Represents LTIP units forfeited by grantee.

Rental Revenue (Tables)

Rental Revenue (Tables)	9 Months Ended
	Sep. 30, 2018
Leases [Abstract]
Schedule of Future Lease Payments Receivables [Table Text Block]	The aggregate annual minimum cash to be received by the Company on the noncancelable operating leases related to its portfolio of facilities in effect as of September 30, 2018, is as follows for the subsequent years ended December 31: 2018 (three months remaining) $ 11,958 2019 48,111 2020 48,947 2021 47,342 2022 46,284 Thereafter 369,036 Total $ 571,678
Schedule Of Concentration Of Rental Revenue [Table Text Block]	The concentration of rental revenue for the three and nine months ended September 30, 2018 and 2017 is as follows: Three Months Ended September 30, Nine Months Ended September 30, Facility 2018 2017 2018 2017 Encompass 11 % 18 % 12 % 22 % Belpre 11 - 7 - OCOM 9 15 10 12 Sherman 6 10 6 - Austin 6 - 7 - East Dallas 6 - 5 - Great Bend 4 8 5 7 Omaha 3 6 4 7 Plano 3 5 3 6 Tennessee 3 - 3 6 Aggregate of all other facilities (1) 38 38 38 40 Total 100 % 100 % 100 % 100 % (1) None individually greater than 3% for the 2018 periods and none greater than 5% for the 2017 periods.

Land Leases (Tables)

Land Leases (Tables)	9 Months Ended
	Sep. 30, 2018
Leases [Abstract]
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	The aggregate minimum cash payments to be made by the Company on these land leases in effect as of September 30, 2018, are as follows for the subsequent years ended December 31: 2018 (three months remaining) $ 27 2019 109 2020 109 2021 109 2022 109 Thereafter 2,234 Total $ 2,697

Organization (Details)

Organization (Details)	9 Months Ended
	Sep. 30, 2018
long-term incentive plan LTIP [Member]
Limited Liability Company (LLC) or Limited Partnership (LP), Members or Limited Partners, Ownership Interest	10.00%
Global Medical REIT GP LLC [Member]
Operating Partnership	90.00%

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Cash and Cash Equivalents) (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017	Sep. 30, 2017	Dec. 31, 2016
Cash and cash equivalents	$ 3,005	$ 5,109	$ 6,777
Restricted cash	817	2,005	2,040
Total cash and cash equivalents and restricted cash	$ 3,822	$ 7,114	$ 8,817	$ 20,612

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017	Sep. 30, 2017	Dec. 31, 2016
Tenant Receivables	$ 1,744	$ 704
Escrow Deposit	2,628	1,638
Deferred Costs and Other Assets	8,590	3,993
Deferred Rent Receivables, Net	7,813	3,842
Security Deposit Liability	3,928	2,128
Receivables Earned But Not Paid Relating To Tenant Rent	621	125
Receivables To Be Collected To Pay Specific Tenant Expenses	1,062	579
Other Assets	1,109	459
Other Deferred Costs, Net	777	151
Capitalized Costs, Acquisitions Of Property	180
Lease Deposit Liability	791	508
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	3,822	7,114	$ 8,817	$ 20,612
Other Assets, Miscellaneous, Current	61
Accumulated Capitalized Interest Costs		316
Prepaid Expense and Other Assets	269	143
Interest Rate Swap [Member]
Derivative Instruments and Hedges, Noncurrent	139
Construction in Progress [Member]
Other Assets	521
Plano Lease [Member]
Security Deposit Liability	$ 3,137	$ 1,620

Property Portfolio (Gross Inves

Property Portfolio (Gross Investment) (Details) - USD ($) $ in Thousands		Aug. 03, 2018	Jul. 03, 2018	Mar. 02, 2018	Feb. 23, 2018	Sep. 30, 2018
Property, Plant and Equipment [Line Items]
Beginning Balance						$ 471,507
Acquisitions	[1]					141,530
Ending Balance						613,037
Moline / Silvis Facility [Member]
Property, Plant and Equipment [Line Items]
Tenant improvements	[2]					2,043
Acquisitions						7,100
Freemont Facility [Member]
Property, Plant and Equipment [Line Items]
Acquisitions						8,497
Gainesville Facility [Member]
Property, Plant and Equipment [Line Items]
Acquisitions					$ 10,500	10,510
Dallas Facility [Member]
Property, Plant and Equipment [Line Items]
Acquisitions				$ 23,300		23,284
Orlando Facility [Member]
Property, Plant and Equipment [Line Items]
Acquisitions						16,414
Belpre Facility [Member]
Property, Plant and Equipment [Line Items]
Acquisitions						64,683
McAllen Facility [Member]
Property, Plant and Equipment [Line Items]
Acquisitions			$ 5,400			5,395
Derby Facility [Member]
Property, Plant and Equipment [Line Items]
Acquisitions		$ 3,600				3,604
Land [Member]
Property, Plant and Equipment [Line Items]
Beginning Balance						42,701
Acquisitions	[1]					14,138
Ending Balance						56,839
Land [Member] | Moline / Silvis Facility [Member]
Property, Plant and Equipment [Line Items]
Tenant improvements	[2]					0
Acquisitions						0
Land [Member] | Freemont Facility [Member]
Property, Plant and Equipment [Line Items]
Acquisitions						162
Land [Member] | Gainesville Facility [Member]
Property, Plant and Equipment [Line Items]
Acquisitions						625
Land [Member] | Dallas Facility [Member]
Property, Plant and Equipment [Line Items]
Acquisitions						6,272
Land [Member] | Orlando Facility [Member]
Property, Plant and Equipment [Line Items]
Acquisitions						2,543
Land [Member] | Belpre Facility [Member]
Property, Plant and Equipment [Line Items]
Acquisitions						3,025
Land [Member] | McAllen Facility [Member]
Property, Plant and Equipment [Line Items]
Acquisitions						1,099
Land [Member] | Derby Facility [Member]
Property, Plant and Equipment [Line Items]
Acquisitions						412
Building [Member]
Property, Plant and Equipment [Line Items]
Beginning Balance						384,338
Acquisitions	[1]					109,165
Ending Balance						493,503
Building [Member] | Moline / Silvis Facility [Member]
Property, Plant and Equipment [Line Items]
Tenant improvements	[2]					0
Acquisitions						4,895
Building [Member] | Freemont Facility [Member]
Property, Plant and Equipment [Line Items]
Acquisitions						8,335
Building [Member] | Gainesville Facility [Member]
Property, Plant and Equipment [Line Items]
Acquisitions						9,885
Building [Member] | Dallas Facility [Member]
Property, Plant and Equipment [Line Items]
Acquisitions						17,012
Building [Member] | Orlando Facility [Member]
Property, Plant and Equipment [Line Items]
Acquisitions						11,720
Building [Member] | Belpre Facility [Member]
Property, Plant and Equipment [Line Items]
Acquisitions						50,526
Building [Member] | McAllen Facility [Member]
Property, Plant and Equipment [Line Items]
Acquisitions						4,296
Building [Member] | Derby Facility [Member]
Property, Plant and Equipment [Line Items]
Acquisitions						2,496
Site And Tenant Improvements [Member]
Property, Plant and Equipment [Line Items]
Beginning Balance						12,818
Acquisitions	[1]					8,224
Ending Balance						21,042
Site And Tenant Improvements [Member] | Moline / Silvis Facility [Member]
Property, Plant and Equipment [Line Items]
Tenant improvements	[2]					2,043
Acquisitions						1,216
Site And Tenant Improvements [Member] | Freemont Facility [Member]
Property, Plant and Equipment [Line Items]
Acquisitions						0
Site And Tenant Improvements [Member] | Gainesville Facility [Member]
Property, Plant and Equipment [Line Items]
Acquisitions						0
Site And Tenant Improvements [Member] | Dallas Facility [Member]
Property, Plant and Equipment [Line Items]
Acquisitions						0
Site And Tenant Improvements [Member] | Orlando Facility [Member]
Property, Plant and Equipment [Line Items]
Acquisitions						756
Site And Tenant Improvements [Member] | Belpre Facility [Member]
Property, Plant and Equipment [Line Items]
Acquisitions						3,966
Site And Tenant Improvements [Member] | McAllen Facility [Member]
Property, Plant and Equipment [Line Items]
Acquisitions
Site And Tenant Improvements [Member] | Derby Facility [Member]
Property, Plant and Equipment [Line Items]
Acquisitions						243
Intangibles [Member]
Property, Plant and Equipment [Line Items]
Beginning Balance						31,650
Acquisitions	[1]					10,003
Ending Balance						41,653
Intangibles [Member] | Moline / Silvis Facility [Member]
Property, Plant and Equipment [Line Items]
Tenant improvements	[2]					0
Acquisitions						989
Intangibles [Member] | Freemont Facility [Member]
Property, Plant and Equipment [Line Items]
Acquisitions						0
Intangibles [Member] | Gainesville Facility [Member]
Property, Plant and Equipment [Line Items]
Acquisitions						0
Intangibles [Member] | Dallas Facility [Member]
Property, Plant and Equipment [Line Items]
Acquisitions						0
Intangibles [Member] | Orlando Facility [Member]
Property, Plant and Equipment [Line Items]
Acquisitions						1,395
Intangibles [Member] | Belpre Facility [Member]
Property, Plant and Equipment [Line Items]
Acquisitions						7,166
Intangibles [Member] | McAllen Facility [Member]
Property, Plant and Equipment [Line Items]
Acquisitions
Intangibles [Member] | Derby Facility [Member]
Property, Plant and Equipment [Line Items]
Acquisitions						$ 453
[1]	The Belpre acquisition included $4,742 of OP Units issued as part of the total consideration for the transaction. As indicated in (1) above, $2,043 of completed construction-in-process costs were reclassified to investment in real estate during the three months ended September 30, 2018. Additionally, an aggregate of $894 of intangible liabilities were acquired from the acquisitions that occurred during the nine months ended September 30, 2018. Accordingly, the total addition to gross investment in real estate funded with cash was $133,851.
[2]	Represents tenant improvements that were completed and placed in service during the three months ended September 30, 2018 related to the Silvis and Sherman facilities that were acquired in January 2018 and June 2017, respectively. These amounts were recorded as construction-in-process within the “Other Assets” line item in the Company’s Consolidated Balance Sheet as of June 30, 2018, and reclassified to investment in real estate once completed.

Property Portfolio (Schedule of

Property Portfolio (Schedule of Recognized Identified Assets Acquired and Liabilities Assumed) (Details) $ in Thousands	Sep. 30, 2018USD ($)
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest	$ 64,051
Land And Site Improvements [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	3,997
Leasing costs [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financial Assets	1,979
Moline / Silvis Facility [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest	6,871
Moline / Silvis Facility [Member] | Building And Tenant Improvements [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	5,862
Moline / Silvis Facility [Member] | In Place Leases [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	343
Moline / Silvis Facility [Member] | Above Market Lease Intangibles [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	219
Moline / Silvis Facility [Member] | Leasing costs [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financial Assets	427
Moline / Silvis Facility [Member] | Below Market Lease Intangible [Member]
Business Acquisition [Line Items]
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Below Market Lease Intangibles	(229)
Moline / Silvis Facility [Member] | Site Improvements [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	249
Orlando Facility [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest	16,404
Orlando Facility [Member] | Land And Site Improvements [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	3,075
Orlando Facility [Member] | Building And Tenant Improvements [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	11,944
Orlando Facility [Member] | In Place Leases [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	808
Orlando Facility [Member] | Above Market Lease Intangibles [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	229
Orlando Facility [Member] | Leasing costs [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financial Assets	358
Orlando Facility [Member] | Below Market Lease Intangible [Member]
Business Acquisition [Line Items]
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Below Market Lease Intangibles	(10)
Belpre Portfolio [Member] | Building And Tenant Improvements [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	53,520
Belpre Portfolio [Member] | In Place Leases [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	2,660
Belpre Portfolio [Member] | Above Market Lease Intangibles [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	2,527
Belpre Portfolio [Member] | Below Market Lease Intangible [Member]
Business Acquisition [Line Items]
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Below Market Lease Intangibles	(632)
Derby Facility [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest	3,581
Derby Facility [Member] | Land And Site Improvements [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	566
Derby Facility [Member] | Building And Tenant Improvements [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	2,585
Derby Facility [Member] | In Place Leases [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	299
Derby Facility [Member] | Above Market Lease Intangibles [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment
Derby Facility [Member] | Leasing costs [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financial Assets	154
Derby Facility [Member] | Below Market Lease Intangible [Member]
Business Acquisition [Line Items]
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Below Market Lease Intangibles	$ (23)

Property Portfolio (summary of

Property Portfolio (summary of the carrying amount of intangible assets and liabilities) (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Assets
Cost	$ 41,653	$ 31,650
Accumulated Amortization	(5,622)	(2,341)
Net	36,031	29,309
Liabilities
Cost	2,284	1,389
Accumulated Amortization	(250)	(98)
Net	2,034	1,291
In-place leases [Member]
Assets
Cost	21,171	17,061
Accumulated Amortization	(3,374)	(1,577)
Net	17,797	15,484
Above Market Ground Lease [Member]
Assets
Cost	707	488
Accumulated Amortization	(22)	(6)
Net	685	482
Above Market Leases [Member]
Assets
Cost	7,381	4,625
Accumulated Amortization	(840)	(220)
Net	6,541	4,405
Leasing Costs [Member]
Assets
Cost	12,394	9,476
Accumulated Amortization	(1,386)	(538)
Net	$ 11,008	$ 8,938

Property Portfolio (summary o_2

Property Portfolio (summary of the acquired lease intangible amortization) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Leases, Acquired-in-Place [Member]
Property, Plant and Equipment [Line Items]
Finite-Lived Intangible Assets, Accumulated Amortization	$ 647	$ 388	$ 1,797	$ 1,022
Lease Costs [Member]
Property, Plant and Equipment [Line Items]
Finite-Lived Intangible Assets, Accumulated Amortization	307	135	848	304
market ground lease [Member]
Property, Plant and Equipment [Line Items]
Finite-Lived Intangible Assets, Accumulated Amortization	6	2	16	4
Above Market Leases [Member]
Property, Plant and Equipment [Line Items]
Finite-Lived Intangible Assets, Accumulated Amortization	240	55	620	73
Below Market Lease [Member]
Property, Plant and Equipment [Line Items]
Finite-Lived Intangible Assets, Accumulated Amortization	$ 56	$ 32	$ 152	$ 63

Property Portfolio (net amortiz

Property Portfolio (net amortization of the acquired lease intangible) (Details) $ in Thousands	Sep. 30, 2018USD ($)
Net Decrease in Revenue
2018 (three months remaining)	$ (189)
2,019	(653)
2,020	(602)
2,021	(605)
2,022	(606)
Thereafter	(2,537)
Total	(5,192)
Net Increase in Expenses
2018 (three months remaining)	958
2,019	3,722
2,020	3,668
2,021	3,053
2,022	2,744
Thereafter	14,660
Total	$ 28,805

Property Portfolio (Details)

Property Portfolio (Details) - USD ($) $ in Thousands

Aug. 03, 2018

Jul. 03, 2018

Mar. 02, 2018

Mar. 22, 2018

Feb. 23, 2018

Feb. 09, 2018

Sep. 30, 2018

Sep. 30, 2017

Sep. 30, 2018

Sep. 30, 2017

Apr. 19, 2018

Jan. 24, 2018

Dec. 31, 2017

Property, Plant and Equipment [Line Items]

Depreciation, Total

$ 3,614

$ 2,176

$ 9,965

$ 5,372

Property, Plant and Equipment, Additions

[1]

141,530

Business Combination, Consideration Transferred, Equity Interests Issued and Issuable

894

Payments for (Proceeds from) Productive Assets

133,851

133,851

213,535

Tenant Improvement Allowances Receivable

17,003

17,003

Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest

64,051

64,051

Other Assets

1,109

$ 1,109

$ 459

Lease Intangibles Asset [Member]

Property, Plant and Equipment [Line Items]

Finite-Lived Intangible Asset, Useful Life

7 years 5 months 26 days

Lease Intangibles Liability [Member]

Property, Plant and Equipment [Line Items]

Finite-Lived Intangible Asset, Useful Life

9 years 7 days

Construction in Progress [Member]

Property, Plant and Equipment [Line Items]

Other Assets

521

$ 521

Real Estate Owned, Transfer to Real Estate Owned

2,043

2,043

$ 0

Moline Facility [Member]

Property, Plant and Equipment [Line Items]

Lessor, Operating Lease, Term of Contract

10 years

Gainesville Facility [Member]

Property, Plant and Equipment [Line Items]

Property, Plant and Equipment, Additions

$ 10,500

10,510

Lessor, Operating Lease, Term of Contract

12 years

Dallas Facility [Member]

Property, Plant and Equipment [Line Items]

Property, Plant and Equipment, Additions

$ 23,300

23,284

Orlando Facilities [Member]

Property, Plant and Equipment [Line Items]

Property, Plant and Equipment, Additions

$ 16,400

Lessee, Operating Lease, Description

one lease has approximately six years remaining in its initial term, with three consecutive five-year renewal options; one lease has approximately six years remaining in its initial term, with four consecutive five-year renewal options; one lease has approximately six years remaining in its initial term, with three consecutive five-year renewal options; and one lease was amended at closing to extend the remaining term to five years with four consecutive five-year renewal options.

Lessor, Operating Lease, Renewal Term

10 years

Belpre Facility [Member]

Property, Plant and Equipment [Line Items]

Property, Plant and Equipment, Additions

64,683

Business Combination, Consideration Transferred, Equity Interests Issued and Issuable

4,742

Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest

$ 64,100

Operating Lease, Weighted Average Remaining Lease Term

11 years 4 months 6 days

McAllen Facility [Member]

Property, Plant and Equipment [Line Items]

Property, Plant and Equipment, Additions

$ 5,400

5,395

Lessor, Operating Lease, Renewal Term

11 years

Lessor, Operating Lease, Term of Contract

10 years

Derby Facility [Member]

Property, Plant and Equipment [Line Items]

Property, Plant and Equipment, Additions

$ 3,600

3,604

Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest

3,581

3,581

Lessor, Operating Lease, Renewal Term

1 year 6 months

Lessor, Operating Lease, Term of Contract

9 years

Moline Silvis Facilities [Member]

Property, Plant and Equipment [Line Items]

Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest

$ 6,900

6,900

Sherman, Silvis, and Gainesville Facilities [Member]

Property, Plant and Equipment [Line Items]

Allowance for Tenant Improvements

$ 721

Fremont Facility [Member]

Property, Plant and Equipment [Line Items]

Property, Plant and Equipment, Additions

$ 8,500

Lessor, Operating Lease, Term of Contract

12 years

[1]

The Belpre acquisition included $4,742 of OP Units issued as part of the total consideration for the transaction. As indicated in (1) above, $2,043 of completed construction-in-process costs were reclassified to investment in real estate during the three months ended September 30, 2018. Additionally, an aggregate of $894 of intangible liabilities were acquired from the acquisitions that occurred during the nine months ended September 30, 2018. Accordingly, the total addition to gross investment in real estate funded with cash was $133,851.

Notes Payable and Revolving C_3

Notes Payable and Revolving Credit Facility (Schedule of net of unamortized discount balances) (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017	Sep. 30, 2017
Debt Instrument [Line Items]
Notes payable, gross	$ 39,475	$ 39,475	$ 98,400
Less: Unamortized debt discount	(832)	(930)
Notes payable, net	$ 38,643	$ 38,545

Notes Payable and Revolving C_4

Notes Payable and Revolving Credit Facility (Scheduled Principal Payments Due On Cantor Loan Note Payable) (Details) - Cantor Loan [Member] - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017	Mar. 31, 2016
Debt Instrument [Line Items]
2,018	$ 0
2,019	0
2,020	0
2,021	315
2,022	449
Thereafter	31,333
Total	$ 32,097	$ 32,097	$ 32,097

Notes Payable and Revolving C_5

Notes Payable and Revolving Credit Facility (Scheduled Principal Payments Due On West Mifflin Note Payable) (Details) - West Mifflin Note Payable [Member] - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017	Sep. 25, 2015
Debt Instrument [Line Items]
2,018	$ 22
2,019	136
2,020	7,220
Total	$ 7,378	$ 7,378	$ 7,378

Notes Payable and Revolving C_6

Notes Payable and Revolving Credit Facility (Schedule of pricing matrix for the Revolver and the Term Loan ) (Details)	Sep. 30, 2018
Less Than 45% [Member]
Leverage Ratio	45.00%
Greater Than 55% [Member]
Leverage Ratio	55.00%
Maximum [Member] | 45% To 50% [Member]
Leverage Ratio	50.00%
Maximum [Member] | 50% To 55% [Member]
Leverage Ratio	55.00%
Minimum [Member] | 45% To 50% [Member]
Leverage Ratio	45.00%
Minimum [Member] | 50% To 55% [Member]
Leverage Ratio	50.00%
Revolving Credit Facility [Member] | London Interbank Offered Rate (LIBOR) [Member] | Less Than 45% [Member]
Debt Instrument, Interest Rate, Stated Percentage	1.40%
Revolving Credit Facility [Member] | London Interbank Offered Rate (LIBOR) [Member] | 45% To 50% [Member]
Debt Instrument, Interest Rate, Stated Percentage	1.65%
Revolving Credit Facility [Member] | London Interbank Offered Rate (LIBOR) [Member] | 50% To 55% [Member]
Debt Instrument, Interest Rate, Stated Percentage	1.90%
Revolving Credit Facility [Member] | London Interbank Offered Rate (LIBOR) [Member] | Greater Than 55% [Member]
Debt Instrument, Interest Rate, Stated Percentage	2.15%
Revolving Credit Facility [Member] | Base Rate [Member] | Less Than 45% [Member]
Debt Instrument, Interest Rate, Stated Percentage	0.40%
Revolving Credit Facility [Member] | Base Rate [Member] | 45% To 50% [Member]
Debt Instrument, Interest Rate, Stated Percentage	0.65%
Revolving Credit Facility [Member] | Base Rate [Member] | 50% To 55% [Member]
Debt Instrument, Interest Rate, Stated Percentage	0.90%
Revolving Credit Facility [Member] | Base Rate [Member] | Greater Than 55% [Member]
Debt Instrument, Interest Rate, Stated Percentage	1.15%
Term Loan [Member] | London Interbank Offered Rate (LIBOR) [Member] | Less Than 45% [Member]
Debt Instrument, Interest Rate, Stated Percentage	1.35%
Term Loan [Member] | London Interbank Offered Rate (LIBOR) [Member] | 45% To 50% [Member]
Debt Instrument, Interest Rate, Stated Percentage	1.60%
Term Loan [Member] | London Interbank Offered Rate (LIBOR) [Member] | 50% To 55% [Member]
Debt Instrument, Interest Rate, Stated Percentage	1.85%
Term Loan [Member] | London Interbank Offered Rate (LIBOR) [Member] | Greater Than 55% [Member]
Debt Instrument, Interest Rate, Stated Percentage	2.10%
Term Loan [Member] | Base Rate [Member] | Less Than 45% [Member]
Debt Instrument, Interest Rate, Stated Percentage	0.35%
Term Loan [Member] | Base Rate [Member] | 45% To 50% [Member]
Debt Instrument, Interest Rate, Stated Percentage	0.60%
Term Loan [Member] | Base Rate [Member] | 50% To 55% [Member]
Debt Instrument, Interest Rate, Stated Percentage	0.85%
Term Loan [Member] | Base Rate [Member] | Greater Than 55% [Member]
Debt Instrument, Interest Rate, Stated Percentage	1.10%

Notes Payable and Revolving C_7

Notes Payable and Revolving Credit Facility (Schedule of outstanding borrowings under the Credit Facility ) (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Long-term Line of Credit	$ 293,273	$ 162,150
Less: Unamortized deferred financing costs	(832)	(930)
Revolving Credit Facility [Member]
Long-term Line of Credit	197,400	164,900
Term Loan [Member]
Long-term Line of Credit	100,000	0
Line of Credit [Member]
Less: Unamortized deferred financing costs	$ (4,127)	$ (2,750)

Notes Payable and Revolving C_8

Notes Payable and Revolving Credit Facility (Schedule of interest rate swap agreement ) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Amount of loss recognized in other comprehensive loss	$ 122	$ 0	$ 122	$ 0
Amount of loss reclassified from accumulated other comprehensive loss into interest expense	(13)	0	(13)	0
Total change in accumulated other comprehensive loss	$ 109	$ 0	$ 109	$ 0

Notes Payable and Revolving C_9

Notes Payable and Revolving Credit Facility (Details) - USD ($) $ in Thousands	1 Months Ended			3 Months Ended			9 Months Ended		12 Months Ended
	Aug. 07, 2018	Dec. 02, 2016	Sep. 25, 2015	Sep. 30, 2018	Sep. 30, 2017	Mar. 31, 2016	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017
Debt Instrument [Line Items]
Amortization of Financing Costs				$ 33	$ 33		$ 98	$ 98
Debt Instrument, Description						Prepayment can only occur within four months prior to the maturity date, except that after the earlier of (a) two years after the loan is placed in a securitized mortgage pool, or (b) May 6, 2020, the Cantor Loan can be fully and partially defeased upon payment of amounts due under the Cantor Loan and payment of a defeasance amount that is sufficient to purchase U.S. government securities equal to the scheduled payments of principal, interest, fees, and any other amounts due related to a full or partial defeasance under the Cantor Loan.The Company secured the payment of the Cantor Loan with the assets, including property, facilities, and rents, held by the GMR Loan Subsidiaries and has agreed to guarantee certain customary recourse obligations, including findings of fraud, gross negligence, or breach of environmental covenants by the GMR Loan Subsidiaries. The GMR Loan Subsidiaries will be required to maintain a monthly debt service coverage ratio of 1.35:1.00 for all of the collateral properties in the aggregate.
Other Operating Activities, Cash Flow Statement							142,900	205,400
Increase (Decrease) in Security Deposits					1,336		1,800	1,487
Repayments of Lines of Credit							$ 10,400	$ 107,000
Debt, Weighted Average Interest Rate				4.35%			4.35%		3.72%
Debt Instrument, Term								4 years 5 months 16 days	2 years 11 months 8 days
Long-term Debt, Gross				$ 39,475	98,400		$ 39,475	$ 98,400	$ 39,475
Debt Instrument, Covenant Description						maintain a monthly debt service coverage ratio of 1.35:1.00 for all of the collateral properties in the aggregate.
Line Of Credit Cash Paid Other							2,750
Interest Rate Swap [Member]
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate	2.88%
Derivative, Amount of Hedged Item	$ 100,000
Derivative Instruments in Hedges, Assets, at Fair Value				139			139		0
Derivative, Maturity Date	Aug. 8, 2023
Minimum [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 340,000
Maximum [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 350,000
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Amortization of Financing Costs				455	308		1,373	742
Line of Credit Facility, Covenant Compliance		The Operating Partnership is subject to ongoing compliance with a number of customary affirmative and negative covenants, including limitations with respect to liens, indebtedness, distributions, mergers, consolidations, investments, restricted payments and asset sales. The Operating Partnership must also maintain (i) a maximum consolidated leverage ratio as of the end of each fiscal quarter of less than (y) 0.65:1.00 for each fiscal quarter ending prior to October 1, 2019 and (z) thereafter, 0.60:1.00, (ii) a minimum fixed charge coverage ratio of 1.50:1.00, (iii) a minimum net worth of $203,795 plus 75% of all net proceeds raised through subsequent equity offerings and (iv) a ratio of total secured recourse debt to total asset value of not greater than 0.10:1.00.
Increase (Decrease) in Security Deposits				3,211			7,872
Long-term Debt, Gross				132,500			132,500
Revolving Credit Facility [Member] | Interest Rate Swap [Member]
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate	2.88%
Derivative, Amount of Hedged Item	$ 100,000
Derivative, Term of Contract	5 years
Revolving Credit Facility [Member] | Minimum [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 340,000
Revolving Credit Facility [Member] | Maximum [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount	500,000			350,000			350,000
Cantor Loan [Member]
Debt Instrument [Line Items]
Long-term Debt, Total				32,097		$ 32,097	$ 32,097		32,097
Debt Instrument, Interest Rate, Stated Percentage						5.22%
Debt Instrument, Maturity Date							Apr. 6, 2026
Interest Expense, Debt				428	428		$ 1,271	1,271
West Mifflin Note Payable [Member]
Debt Instrument [Line Items]
Long-term Debt, Total			$ 7,378	7,378			7,378		$ 7,378
Debt Instrument, Interest Rate, Stated Percentage			3.72%
Debt Instrument, Description			The West Mifflin facility serves as collateral for the note. The note requires a quarterly fixed charge coverage ratio of at least 1:1, a quarterly minimum debt yield of 0.09:1.00, and annualized Operator EBITDAR (as defined in the note) measured on a quarterly basis of not less than $6,000.
Interest Expense, Debt				$ 72	$ 70		$ 211	$ 209
The Revolver [Member] | Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount	250,000
The Term loan [Member] | Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 100,000

Schedule of Company's Board had

Schedule of Company's Board had declared cash dividends on common stock (Details) - USD ($) $ / shares in Units, $ in Thousands		9 Months Ended
		Sep. 30, 2018	Dec. 31, 2017
Dividend Amount		$ 6,109	$ 5,638
Common Stock [Member] | Dividend Declared On 15 December
Record Date		Dec. 26, 2017
Applicable Quarter		Q4 2017
Payment Date		Jan. 10, 2018
Dividend Amount	[1]	$ 4,552
Dividends per Share		$ 0.20
Common Stock [Member] | Dividend Declared On 07 March
Record Date		Mar. 22, 2018
Applicable Quarter		Q1 2018
Payment Date		Apr. 10, 2018
Dividend Amount	[1]	$ 4,691
Dividends per Share		$ 0.20
Common Stock [Member] | Dividend Declared On 15 June
Record Date		Jun. 26, 2018
Applicable Quarter		Q2 2018
Payment Date		Jul. 11, 2018
Dividend Amount	[1]	$ 4,786
Dividends per Share		$ 0.20
Common Stock [Member] | Dividend Declared On 10 September
Record Date		Sep. 20, 2018
Applicable Quarter		Q3 2018
Payment Date		Oct. 10, 2018
Dividend Amount	[1]	$ 4,889
Dividends per Share		$ 0.20
Preferred Stock [Member] | Dividend Declared On 15 December
Record Date		Jan. 15, 2018
Applicable Quarter		Q4 2017
Payment Date		Jan. 31, 2018
Dividend Amount		$ 1,455
Amount Accrued		$ 0
Dividends per Share		$ 0.46875
Preferred Stock [Member] | Dividend Declared On 07 March
Record Date		Apr. 15, 2018
Applicable Quarter		Q1 2018
Payment Date		Apr. 30, 2018
Dividend Amount		$ 1,456
Amount Accrued		$ 0
Dividends per Share		$ 0.46875
Preferred Stock [Member] | Dividend Declared On 15 June
Record Date		Jul. 15, 2018
Applicable Quarter		Q2 2018
Payment Date		Jul. 31, 2018
Dividend Amount		$ 1,455
Amount Accrued		$ 0
Dividends per Share		$ 0.46875
Preferred Stock [Member] | Dividend Declared On 10 September
Record Date		Oct. 15, 2018
Applicable Quarter		Q3 2018
Payment Date		Oct. 31, 2018
Dividend Amount		$ 1,455
Amount Accrued	[2]	$ 970
Dividends per Share		$ 468.75
[1]	Includes distributions on granted LTIP units and OP Units issued to third parties.
[2]	Represents the accrued portion of the second quarter 2018 dividend as of September 30, 2018.

Stockholders' Equity (Details)

Stockholders' Equity (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	1 Months Ended	3 Months Ended	9 Months Ended		12 Months Ended
	Aug. 17, 2018	Sep. 30, 2018	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017
Preferred Stock, Shares Authorized		10,000	10,000		10,000
Preferred Stock, Par or Stated Value Per Share		$ 0.001	$ 0.001		$ 0.001
Preferred Stock, Shares Issued		3,105	3,105		3,105
Common Stock, Shares Authorized		500,000	500,000		500,000
Common Stock, Par or Stated Value Per Share		$ 0.001	$ 0.001		$ 0.001
Common Stock, Shares, Outstanding		22,003	22,003		21,631
Dividends Payable		$ 6,109	$ 6,109		$ 5,638
Preferred Stock, Liquidation Preference Per Share		$ 25	$ 25
Payments of Ordinary Dividends, Preferred Stock and Preference Stock			$ 4,366
Limited Partners' Capital Account, Units Issued		1,857	1,857		1,246
Payments of dividens, Common Stock, OP and LTIP Units			$ (14,075)	$ (10,815)
Partners' Capital Account, Units, Sale of Units			611		1,246
Noncontrolling Interest, Increase from Subsidiary Equity Issuance			$ 4,742		$ 11,532
Limited Partners' Capital Account		$ 16,274	16,274		11,532
Proceeds from Issuance of Common Stock			3,209	33,795
Stock To Be Issued During Period Value ATM Offering	$ 50,000
Stock Issued During Period, Value, New Issues			3,452
At The Market [Member]
Proceeds from Issuance of Common Stock	$ 3,209
Deferred Offering Costs		59	59
Commission On Sale Of Stock		$ 53
Stock Issued During Period, Shares, New Issues		372
Stock Issued During Period, Value, New Issues		$ 3,505
Payments of Stock Issuance Costs		243
Common Stock [Member]
Dividends Payable		$ 180	180	$ 92
Payments of Ordinary Dividends			46
Noncontrolling Interest, Increase from Subsidiary Equity Issuance			$ 0
Stock Issued During Period, Shares, New Issues			372
Stock Issued During Period, Value, New Issues			$ 0
Series A Preferred Stock [Member]
Preferred Stock, Shares Issued		3,105	3,105
Dividends Payable, Amount Per Share		$ 1,875	$ 1,875
Preferred Stock, Liquidation Preference Per Share		$ 25	$ 25
Preferred Stock, Dividend Rate, Percentage			7.50%
Long Tem Incentives Plan Units [Member]
Dividends Payable		$ 250	$ 250		$ 116

Related Party Transactions (Due

Related Party Transactions (Due to Related Parties, Net) (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018		Sep. 30, 2017
Related Party Transaction [Line Items]
Balance, Beginning				$ (1,036)
Management fee expense incurred		$ (1,104)	$ (804)	(3,280)	[1]	$ (2,059)
Management fees paid to Advisor	[1]			3,239
(Loans to) repayments from related parties				49		$ (38)
Balance, Ending		(1,028)		(1,028)
Advisor [Member]
Related Party Transaction [Line Items]
(Loans to) repayments from related parties	[2]			9
Other related parties [Member]
Related Party Transaction [Line Items]
(Loans to) repayments from related parties	[2]			40
Due To Advisor Mgmt Fees [Member]
Related Party Transaction [Line Items]
Balance, Beginning				(1,064)
Management fee expense incurred	[1]			(3,280)
Management fees paid to Advisor	[1]			3,239
Balance, Ending		(1,105)		(1,105)
Due To Advisor Mgmt Fees [Member] | Advisor [Member]
Related Party Transaction [Line Items]
(Loans to) repayments from related parties	[2]			0
Due To Advisor Mgmt Fees [Member] | Other related parties [Member]
Related Party Transaction [Line Items]
(Loans to) repayments from related parties	[2]			0
Due To Advisor Other Funds [Member]
Related Party Transaction [Line Items]
Balance, Beginning				9
Management fee expense incurred	[1]			0
Management fees paid to Advisor	[1]			0
Balance, Ending		18		18
Due To Advisor Other Funds [Member] | Advisor [Member]
Related Party Transaction [Line Items]
(Loans to) repayments from related parties	[2]			9
Due To Advisor Other Funds [Member] | Other related parties [Member]
Related Party Transaction [Line Items]
(Loans to) repayments from related parties	[2]			0
Due to from Other Related party [Member]
Related Party Transaction [Line Items]
Balance, Beginning				19
Management fee expense incurred	[1]			0
Management fees paid to Advisor	[1]			0
Balance, Ending		$ 59		59
Due to from Other Related party [Member] | Advisor [Member]
Related Party Transaction [Line Items]
(Loans to) repayments from related parties	[2]			0
Due to from Other Related party [Member] | Other related parties [Member]
Related Party Transaction [Line Items]
(Loans to) repayments from related parties	[2]			$ 40
[1]	Net amount accrued of $41 consists of $3,280 in management fee expense incurred, net of $3,239 of accrued management fees that were paid to the Advisor. This represents a cash flow operating activity.
[2]	Aggregate amount of $49 represents amounts paid by the Company on behalf of several related party entities for miscellaneous purposes. This represents a cash flow investing activity.

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended			12 Months Ended
		Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018		Sep. 30, 2017	Dec. 31, 2017	May 08, 2017
Related Party Transaction [Line Items]
Management Fee Expense		$ 1,104	$ 804	$ 3,280	[1]	$ 2,059
Payment for Management Fee				3,239		1,876
Increase (Decrease) in Due to Related Parties				41		183
(Loans to) repayments from related parties				49		$ (38)
Due To Advisor Mgmt Fees [Member]
Related Party Transaction [Line Items]
Management Fee Expense	[1]			3,280
Payment for Management Fee				$ 1,105			$ 1,064
Mr. Jamie Barber [Member]
Related Party Transaction [Line Items]
Accrued Salaries, Current								$ 125
[1]	Net amount accrued of $41 consists of $3,280 in management fee expense incurred, net of $3,239 of accrued management fees that were paid to the Advisor. This represents a cash flow operating activity.

Stock-Based Compensation Time-b

Stock-Based Compensation Time-based vesting (Details) shares in Thousands	9 Months Ended
	Sep. 30, 2018shares
LTIP units outstanding as of September 30, 2018	588
Long Tem Incentives Plan Units [Member] | 2017 Program [Member]
LTIP units granted	57	[1]
Long Tem Incentives Plan Units [Member] | Equity Incentive Plan 2016 [Member]
LTIP units outstanding as of December 31, 2017	436
LTIP units granted	57	[2]
LTIP units redeemed in cash or forfeited	(35)	[3]
LTIP units outstanding as of September 30, 2018	588
Long Tem Incentives Plan Units [Member] | 2018 Time based [Membe]
LTIP units granted	73	[4]
[1]	The 57 LTIP units represents earned and granted units from the previously disclosed 2017 annual awards (the “Annual Awards”). On March 5, 2018 the Compensation Committee of the Board (the “Compensation Committee”) determined the extent to which the Company achieved the performance goals related to the 2017 Annual Awards and determined the number of LTIP units that each grantee was entitled to receive. These grants vested 50% on March 5, 2018, the determination date, and 50% vest on December 31, 2018.
[2]	The 57 LTIP units are comprised of the following: on March 5, 2018, the Board approved grants of an aggregate of 36 LTIP Units to employees of the Advisor, which vest 50% on March 5, 2020 and 50% on March 5, 2021; on May 30, 2018 and June 14, 2018 the Board approved grants of an aggregate of 21 LTIP Units to independent directors of the Board, which vest on May 30, 2019 and June 14, 2019.
[3]	The 35 LTIP units is comprised of 34 vested units that the Company elected to redeem in cash for $263 and the remaining unvested unit was forfeited.
[4]	The 73 LTIP units represent grants approved by the Board on March 5, 2018 and are subject to the terms and conditions of the 2018 LTIP Unit Award Agreements between the Company and each grantee. These grants vest in equal one-third increments on each of March 5, 2019, March 5, 2020, and March 5, 2021.

Stock-Based Compensation Vested

Stock-Based Compensation Vested and unvested LTIP units (Details) shares in Thousands	9 Months Ended
	Sep. 30, 2018shares
Total vested units	285
Unvested units:
Total unvested units	303
LTIP units outstanding as of September 30, 2018	588
Advisor [Member]
Unvested units:
Granted	282
Independent directors [Member]
Unvested units:
Granted	21

Stock-Based Compensation Long-T

Stock-Based Compensation Long-Term Awards (Details) shares in Thousands	9 Months Ended
	Sep. 30, 2018shares
Total Annual Long term Awards [Member]
Net 2017 Program LTIP awards as of December 31, 2017	182
LTIP unit forfeitures	(4)	[1]
Net annual and long-term LTIP awards as of June 30, 2018	367
Two Thousand Seventeen Program [Member] | Annual Awards [Member]
Net 2017 Program LTIP awards as of December 31, 2017	84
LTIP units granted via the Performance Program	(57)	[2]
LTIP units not earned under the 2017 Performance Program – Annual Awards	(27)	[3]
LTIP unit forfeitures		[1]
Net annual and long-term LTIP awards as of June 30, 2018	0
Two Thousand Seventeen Program [Member] | Annual Awards [Member] | Total Annual Long term Awards [Member]
LTIP units not earned under the 2017 Performance Program – Annual Awards	(27)	[3]
Two Thousand Seventeen Program [Member] | Long-Term Awards [Member]
Net 2017 Program LTIP awards as of December 31, 2017	98
LTIP units granted via the Performance Program	0	[4]
LTIP units not earned under the 2017 Performance Program – Annual Awards	0	[3]
LTIP unit forfeitures	(2)	[1]
Net annual and long-term LTIP awards as of June 30, 2018	96
2018 Program [Member] | Annual Awards [Member]
Net 2017 Program LTIP awards as of December 31, 2017	0
LTIP units granted via the Performance Program	163	[5]
LTIP units not earned under the 2017 Performance Program – Annual Awards	0	[3]
LTIP unit forfeitures	(2)	[1]
Net annual and long-term LTIP awards as of June 30, 2018	161
2018 Program [Member] | Annual Awards [Member] | Total Annual Long term Awards [Member]
LTIP units granted via the Performance Program	163	[5]
2018 Program [Member] | Long-Term Awards [Member]
Net 2017 Program LTIP awards as of December 31, 2017	0
LTIP units granted via the Performance Program	110	[4]
LTIP units not earned under the 2017 Performance Program – Annual Awards	0	[3]
LTIP unit forfeitures		[1]
Net annual and long-term LTIP awards as of June 30, 2018	110
2018 Program [Member] | Long-Term Awards [Member] | Total Annual Long term Awards [Member]
LTIP units granted via the Performance Program	110	[4]
[1]	Represents LTIP units forfeited by grantee.
[2]	This amount represents grants from the 2017 Program Annual Awards. Refer to the “Time-Based Grants” table above which presents these grants as earned and time-based.
[3]	On March 5, 2018 the Compensation Committee determined the extent to which the Company achieved the performance goals and concluded that these target awards were not earned.
[4]	These target Long-Term Awards were approved by the Board on March 5, 2018 and are subject to the terms and conditions of the 2018 LTIP Unit Award Agreements between the Company and each grantee.
[5]	These target Annual Awards were approved by the Board on April 9, 2018 and are subject to the terms and conditions of the 2018 LTIP Unit Award Agreements between the Company and each grantee.

Stock-Based Compensation (Detai

Stock-Based Compensation (Details) - USD ($) $ in Thousands		Mar. 05, 2021	Mar. 05, 2020	Mar. 05, 2019	Mar. 05, 2018	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Share-based Compensation						$ 741	$ 340	$ 1,978	$ 1,481
Share-based Compensation Arrangement by Share-based Payment Award, Employee Subscription Rate After Performance Period								The number of LTIP units earned under the Long-Term Awards will be determined as soon as reasonably practicable following the end of the three-year performance period (2020 or 2021 depending on the program) based on the Company’s TSR on an absolute basis (as to 75% of the Long-Term Award) and relative to the SNL Healthcare REIT Index (as to 25% of the Long-Term Award).
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage								75.00%
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized						$ 3,567		$ 3,567
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition								2 years 2 months 1 day
Share Based Compensation Arrangement By Share Based Payment Award Non Option Vested Redeemed In Cash								34,000
Stock Redeemed or Called During Period, Value								$ 263
Performance Goals For Awards								As of September 30, 2018, management estimated that the Performance Goals would be met at a 75% level, and accordingly, applied 75% to the net target 2018 Program Annual Awards to estimate the 2018 Program Annual Awards expected to be earned at the end of the performance period.
Additional Earn Up Rate For Grantee								150.00%
2017 Performance Program [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted					36,000			57,000
2017 Program [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage				50.00%	50.00%
Long Term Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage		50.00%	50.00%
Long Tem Incentives Plan Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage		50.00%	50.00%
Long Tem Incentives Plan Units [Member] | 2016 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant						277,000		277,000
Common Stock, Capital Shares Reserved for Future Issuance						1,232,000		1,232,000
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted	[1]							57
Long Tem Incentives Plan Units [Member] | 2017 Program [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted	[1]							57,000
Long-Term Awards [Member] | Share-based Compensation Award, Tranche Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage								50.00%
Long-Term Awards [Member] | Share-based Compensation Award, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage								50.00%
Long-Term Awards [Member] | Long Term Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate						200.00%		200.00%
[1]	The 57 LTIP units represents earned and granted units from the previously disclosed 2017 annual awards (the “Annual Awards”). On March 5, 2018 the Compensation Committee of the Board (the “Compensation Committee”) determined the extent to which the Company achieved the performance goals related to the 2017 Annual Awards and determined the number of LTIP units that each grantee was entitled to receive. These grants vested 50% on March 5, 2018, the determination date, and 50% vest on December 31, 2018.

Rental Revenue (Schedule of Fut

Rental Revenue (Schedule of Future Lease Payments Receivables) (Details) $ in Thousands	Sep. 30, 2018USD ($)
2018 (three months remaining)	$ 11,958
2,019	48,111
2,020	48,947
2,021	47,342
2,022	46,284
Thereafter	369,036
Total	$ 571,678

Rental Revenue (Schedule Of Ren

Rental Revenue (Schedule Of Rental Revenue) (Details)		3 Months Ended		9 Months Ended
		Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Concentration Risk, Percentage				3.00%	5.00%
Rental Revenue [Member]
Concentration Risk, Percentage		100.00%	100.00%	100.00%	100.00%
Encompass [Member] | Rental Revenue [Member]
Concentration Risk, Percentage		11.00%	18.00%	12.00%	22.00%
Belpre [Member] | Rental Revenue [Member]
Concentration Risk, Percentage		11.00%	0.00%	7.00%	0.00%
OCOM [Member] | Rental Revenue [Member]
Concentration Risk, Percentage		9.00%	15.00%	10.00%	12.00%
Sherman [Member] | Rental Revenue [Member]
Concentration Risk, Percentage		6.00%	10.00%	6.00%	0.00%
Austin [Member] | Rental Revenue [Member]
Concentration Risk, Percentage		6.00%	0.00%	7.00%	0.00%
East Dallas [Member] | Rental Revenue [Member]
Concentration Risk, Percentage		6.00%	0.00%	5.00%	0.00%
Great Bend [Member] | Rental Revenue [Member]
Concentration Risk, Percentage		4.00%	8.00%	5.00%	7.00%
Omaha [Member] | Rental Revenue [Member]
Concentration Risk, Percentage		3.00%	6.00%	4.00%	7.00%
Plano [Member] | Rental Revenue [Member]
Concentration Risk, Percentage		3.00%	5.00%	3.00%	6.00%
Tennessee [Member] | Rental Revenue [Member]
Concentration Risk, Percentage		3.00%	0.00%	3.00%	6.00%
All Other Facilities [Member] | Rental Revenue [Member]
Concentration Risk, Percentage	[1]	38.00%	38.00%	38.00%	40.00%
[1]	None individually greater than 3% for the 2018 periods and none greater than 5% for the 2017 periods.

Rental Revenue (Details)

Rental Revenue (Details)	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Concentration Risk, Percentage	3.00%	5.00%

Land Leases (Schedule Of Future

Land Leases (Schedule Of Future Minimum Rental Payments) (Details) $ in Thousands	Sep. 30, 2018USD ($)
2018 (three months remaining)	$ 27
2,019	109
2,020	109
2,021	109
2,022	109
Thereafter	2,234
Total	$ 2,697

Land Leases (Details)

Land Leases (Details)	Sep. 30, 2018
Moline Facility [Member]
Lessee, Operating Lease, Renewal Term	10 years
Silvis facility [Member]
Lessee, Operating Lease, Renewal Term	67 years

Subsequent Events (Details)

Subsequent Events (Details) $ in Millions	Nov. 02, 2018USD ($)
Subsequent Event [Member] | Great Bend Regional Hospital [Member]
Subsequent Event [Line Items]
Disposal Group, Including Discontinued Operation, Consideration	$ 32